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Abstract 
The purpose of this thesis was to create best practice recommendations to treat postoperative 
nausea and vomiting (PONV) during the first 24 postoperative hours in patients undergoing 
general anesthesia. PONV is a multifaceted and unpleasant phenomenon, increasing length and 
cost of stay. Pharmacotherapy is most often used to treat PONV though it may not be the most 
cost-effective intervention nor patient preference . The literature review was conducted through 
CINAHL, Embase and PubMed. The keywords used to search were PONV, postoperative nausea 
and vomiting, aromatherapy, P6 acupuncture, supplemental oxygen, supplemental fluid therapy, 
intravenous fluid therapy, pharmacotherapy, ondansetron, and 5HT3 antagonists. Dates of 
publication were limited to 2008 to 2018. The literature revealed evidence to support using 
acupuncture on the P6 acupoint site (N = 5), supplemental intravenous fluids with crystalloids (N 
= 4) and the use of ondansetron as a first line antiemetic in combination with dexamethasone (N 
= 4). Based on these results, a best practice recommendation for integrative nursing to treat 
PONV includes a bundle of interventions of controlled breathing, acupuncture of the P6 
acupoint, intraoperative supplemental intravenous fluid of 30 mL/kg/hour crystalloid solutions, 
and the use of ondansetron as a first line antiemetic therapy combined with dexamethasone. 
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CHAPTER 1 
Introduction 
Statement of Purpose 
The purpose of this thesis is to create best practice recommendations to better treat and 
prevent postoperative nausea and vomiting (PONV) during the first 24 postoperative hours in 
patients recovering from procedures under general anesthesia. The best practice 
recommendations will be developed using evidence based research and the principles of 
integrative nursing focusing on a range of interventions from least to most invasive for PONV 
(Cutshall & Van Getson, 2014). The background information on the importance of this issue will 
be discussed as well as the relevance of this issue as related to the field of nursing practice. After 
reviewing and critically analyzing the background information, the relevance to nursing, and 
findings from evidence based research, a best practice recommendation will be proposed and 
detailed with the objective of finding methods of treating PONV for patients in the first 24 hours 
after recovering from general anesthesia with an integrative approach. 
Background of Issue Importance 
Several medications used for anesthesiology and following surgical procedures can cause 
nausea and vomiting. These symptoms are not only unpleasant for the patient and affect their 
quality of life, but can also lead to a host of negative consequences. There is an important 
distinction between nausea and vomiting in which nausea is an unpleasant and subjective feeling 
of the need or urge to vomit often associated with tachycardia, flushing and pallor, while 
vomiting is the point at which the abdominal muscles contract forcefully and result in the 
“expulsion of stomach contents” (Cuthshall & Van Getson, 2014, p. 215). Singh, Yoon and Kuo 
(2016) name nausea as the “neglected symptom” (p. 98) due to the fact that many of the current 
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therapies used aim to alleviate vomiting or to improve the motility of the gastrointestinal tract. 
Additionally, acute nausea is considered to be nausea that occurs within 24 hours of a trigger or 
after taking a medication and delayed nausea is considered to be any nausea that develops 24 
hours after a trigger or after taking a medication (Cutshall & Van Getson, 2014). 
Evidence has shown that PONV can increase the medical costs related to increased time 
spent in the PACU (post-anesthesia care unit), increase recovery times, affect patient satisfaction 
with care, and can even cause significant postoperative complications (Cutshall & Van Getson, 
2014). As many as 20% to 30% of all surgical patients will experience PONV though the 
prevalence of PONV for those with a number of risk factors can reach as high as 70% to 80% 
(Cutshall & Van Getson, 2014). Current pharmacotherapies used to treat PONV are additive in 
that they decrease the relative risk of PONV by about 25% each time greatly improving PONV, 
however this also means that the current pharmacological approaches fail to fully eradicate 
PONV (Horn, Wallisch, Homanics & Williams, 2014).  
Significance of Problem 
PONV is thought to be caused by a number of interacting factors and is commonly 
attributed to the inhaled anesthetics used during surgery, opioids used to manage pain 
postoperatively, pain that has gone unrelieved, hypotension and early oral intake (Cutshall & 
Van Getson, 2014). Additionally, specific types of procedures and preexisting medical 
conditions may also increase the risk of PONV (Cutshall & Van Getson, 2014).  Procedures that 
are thought to predispose patients to develop PONV include laparoscopic procedures, 
gynecological procedures, cholecystectomies, and surgeries involving the ear, nose or throat 
(Horn et al., 2014). Horn et al. (2014) site the biggest risk predictors of developing PONV to be 
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being of a young age, being a non-smoker, being a female, and having a personal or family 
history of motion sickness.  
Horn et al. (2014) admit there are many pathophysiological pathways involved in nausea 
and vomiting and, due to the fact that nausea cannot be “directly measured in non-human 
animals” (p. 58) the neurobiology of nausea is not fully understood. The caudal hindbrain houses 
the neural circuits involved in emesis including the respiratory nuclear groups found in the 
reticular formation and the nucleus of the solitary tract (Horn et al., 2014).  According to Horn et 
al. (2014) activation of “descending pathways from the forebrain” (p. 58) can also produce 
vomiting. Evidence shows that inhaled anesthetics can produce emesis by affecting the vestibular 
system, “stimulate vagal afferent fibers” (p. 58), and enhance the function of 5-HT3 receptors 
(Horn et al., 2014). Because surgical procedures often cause inflammation, it is possible that 
some of PONV is due to inflammation and the antiemetics used to control PONV such as 5-HT3 
antagonists are effective due to the anti-inflammatory properties (Horn et al., 2014). Lastly, 
evidence has shown that the vomiting center can be activated by the stimulation of the 
gastrointestinal tract by nitrous oxide used during surgical procedures (Cutshall & Van Getson, 
2014). While there are many potential causes of PONV, it is clear that both the opioids used to 
manage postoperative pain and the inhaled anesthetics used during surgery disrupt the 
gastrointestinal tract and cause “gastrointestinal dysrhythmias” (p. 59) which are known 
biomarkers for both vomiting and nausea (Horn et al., 2014).  
Parra-Sanchez et al. (2012) conducted a study to analyze the cost of PONV in 100 
patients undergoing ambulatory surgeries. The study looked at the time the staff spent with each 
patient, the incidence of PONV, the duration of recovery, the supplies used to treat PONV, and 
quality of life of patients experiencing PONV up to the third postoperative day (Parra-Sanchez et 
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al., 2012). Parra-Sanchez et al. (2012) found that when compared with patients who did not 
experience PONV, those who experienced PONV spent one hour longer in the PACU (p = 
0.001), had a significantly higher time spent with the nursing staff (p  = 0.02), had significantly 
higher costs for postoperative recovery, a difference between $730 and $640 (p = 0.006) and had 
reported significantly worsened qualities of life (p  < 0.001).  It was found that patients would be 
willing to pay an additional $75 dollars to avoid PONV and the decreased quality of life 
associated with PONV (Parra-Sanchez et al., 2012).  
As stated by Cutshall and Van Getson (2014), a nurse using an integrative approach 
looking at nausea looks at the whole person as a system and looks for all potential causes and 
interventions for PONV. The integrative nurse should then move from the least invasive 
intervention possible to more invasive with the goal of facilitating the natural process of healing 
(Cutshall & Van Getson, 2014). When considering this integrative nursing approach, it is clear 
that not one intervention will be completely effective for all patients and that not all patients 
require the same invasiveness of intervention.  
Summary 
 The purpose of this thesis is to develop a best practice recommendation to better treat 
PONV in the first 24 postoperative hours both in the PACU and following discharge in patients 
undergoing procedures with general anesthesiology using a variety of interventions with an 
integrative approach. Parra-Sanchez et al. (2012) showed that PONV can not only worsen quality 
of life but increase time spent in the PACU, increase the time demands on nursing staff, and 
increase patient costs. Though there are many promising and helpful pharmacological treatments 
for PONV, none of them fully eliminate PONV (Horn et al., 2014). This thesis is intended to 
discover not only which treatments are beneficial for treating PONV, but also to determine 
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which treatments and interventions need more research and can be improved upon. With the 
information gathered throughout this thesis, evidence based best practice recommendations can 
be developed to better treat acute PONV in patients who went under general anesthesiology. 
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CHAPTER 2 
Review of Literature 
 To complete the literature review included in this thesis, searches of PubMed, CINAHL 
and EmBase were conducted for articles published between the years of 2013 and 2018 in peer 
reviewed journals. Search parameters were expanded to include articles published as early as 
2008 if results from initial searches did not yield a sufficient number of articles or articles of 
good quality and rigorous study design. Search keywords included “postoperative nausea and 
vomiting OR PONV” with subheadings of “aromatherapy,” “P6 acupuncture,” “acupuncture,” 
“supplemental oxygen,” “oxygen,” “supplemental fluid therapy,” “intravenous fluid therapy,” 
“pharmacotherapy,” “ondansetron,” and “5HT3 antagonists.” A total of 27 articles were selected 
to be included in the literature based on time of publication, study design, and the type of 
intervention examined for prevention and treatment of postoperative nausea and vomiting 
(PONV). The information provided in these 27 articles will be synthesized to create a best 
practice recommendation for the prevention and treatment of PONV with an integrative 
approach. 
Aromatherapy: Ginger Essence, Peppermint Oil and Isopropyl Alcohol 
Investigating the Effects of Inhaling Ginger Essence on Post-Nephrectomy Nausea and 
Vomiting 
Adib-Hajibaghery and Hosseini (2015) assert that there is little known information about 
the relationship between inhaled ginger and PONV, however it is known that the active 
ingredients in ginger have anti-inflammatory, antiemetic and antipyretic properties and also 
reduces gastrointestinal distress. The purpose of their randomized control trial with level of 
evidence of II, was to determine and evaluate the effectiveness of inhaled ginger essence on 
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PONV in post-nephrectomy patients under general anesthesia. Convenience sampling was used 
to recruit 120 patients from a teaching hospital in Iran. Inclusion criteria consisted of being of 
American Society of Anesthesiology (ASA) class II status, being a participant 18 years of age or 
older, being able to speak and write Persian, having no known allergies to ginger, having no 
balance hearing or impairments, having no known history of allergies, motion sickness, asthma 
or olfactory problems and having nothing by mouth for at least eight hours, no antiemetic 
medications for at least 24 hours and no chemotherapy for 18 to 48 hours before surgery. 
Exclusion criteria for the study included developing any reactions or sensitivities to ginger, 
withdrawal from the study, and developing acute hemodynamic instability. In order to prevent 
crossover between the intervention of inhaling ginger essence and control of inhalation of normal 
saline, the participants on the first day were randomly assigned to the intervention with a coin 
toss, and following the first day alternations between control and intervention took place until 
completion of study. A power analysis was conducted and determined that each group would 
need 51 participants to yield statistically significant results. In the end, each group had a total of 
60 participants to allow for possible drop out however there was no attrition. A two inch by two 
inch gauze pad with either two drops of normal saline, or two drops of ginger essence was 
attached to patients’ clothing every 30 minutes for two hours in the recovery unity and once 
again at the sixth hour on the ward. Data was conducted with a visual analog scale (VAS) on a 
scale of one to ten with zero being “no nausea” and ten being “most severe nausea” every hour 
for the first six hours following surgery (Adib-Hajibaghery & Hosseini, 2015). Each group was 
compared with Chi-squared tests and Fisher’s tests. Variance analysis was completed both 
between and within groups with statistical significance set at p ≤ 0.05. Demographics between 
groups were not statistically significant save that of amount of blood transfused (p = 0.02) which 
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was higher in the experimental group than control group, and systolic blood pressures (p = 0.01) 
and mg of ondansetron administered (p = 0.02) which were both lower in the experiment group 
than control group. Results from the study indicate that the number of episodes of vomiting were 
significantly lower at T4 and were significantly lower for the intervention group (p < 0.001). 
Additionally, the mean nausea intensity scores were consistently higher in the control group until 
the sixth hour following surgery (P < 0.001) and the mean nausea score did not decrease 
significantly for the control group. On the other hand, the mean nausea scores did decrease for 
the intervention group (p < 0.001). The rescue antiemetic of ondansetron was administered to 
patients who had severe or moderate nausea after they met with a physician. The dose of 
ondansetron administered was significantly higher in the control group than the intervention 
group (p = 0.001). The authors conclude that inhaled ginger essence is beneficial for 
management of PONV and can be used as an effective antiemetic, however, further studies need 
to be conducted with inhaled ginger essence in larger populations. The authors note that their 
findings are not consistent with several studies that indicate that ginger either has no effect on 
PONV or increased the incidence of nausea. Additionally, the authors note that the results could 
have been altered by shallow breathing of patients in recovery caused by the general anesthetic. 
The authors hypothesize shallow breathing may have limited the absorption of the ginger 
essence, however shallow breathing was observed in both control and intervention groups and 
therefore would have affected each group equally. Because of the contradictory results of this 
study in relation to other studies, as well as the very specific sample for this study, the results 
should be interpreted with caution and may not be generalizable or applicable to larger clinical 
populations.  
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Effectiveness of Ginger Essential Oil on Postoperative Nausea and Vomiting in Abdominal 
Surgery Patients 
 Lee and Shin (2017) conducted a quasi-experimental study with level of evidence of III 
in Seoul, South Korea to determine the effectiveness of ginger essential oil aromatherapy on 
PONV in patients who underwent major abdominal surgeries. Convenience sampling was used 
to recruit a total of 60 patients from three different surgical units in the same hospital in Seoul. 
Inclusion criteria included being scheduled for major abdominal surgeries including gallbladder, 
liver, appendix and pancreas surgeries, being between 20 and 70 years of age, being under 
general anesthesia for at least 60 minutes, ability to understand the study, being alert and 
oriented to time, place, situation and person upon admission and requesting patient controlled 
analgesia (PCA) postoperatively for pain. Exclusion criteria included having severe kidney, heart 
or lung diseases, having allergies to medications or ginger essence or other essential oils and 
those receiving chemotherapy. The authors conducted a power analysis and determined a target 
sample size of 30 participants in each group to yield results of statistical significance. Thirty 
participants were assigned to each group with no attrition yielding a total of 60 participants with 
30 in each group. Participants were not randomly assigned and instead the first 30 participants 
meeting inclusion and exclusion criteria received the intervention of inhaled ginger essential oil 
and the following 30 received the control intervention of inhaled normal saline. The non-random 
assignment of groups was done in order to ensure that in the recovery area there would not be 
additional inhalants that would alter the results of the study. Upon arrival in the recovery unit 
after leaving the post-anesthesia care unit (PACU), patients were given an aromatherapy 
necklace which contained 0.3 mL of normal saline or 0.3 mL of organic ginger essential oil to 
wear for the first 24 postoperative hours. A version of the Index of Nausea, Vomiting and 
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Retching (INVR) scale was used to collect data on a numerical scale from zero to 32 with 32 
being severe nausea. Participants were asked about both the duration and intensity of their 
nausea, vomiting and retching at six, 12 and 24 hours after initiation of aromatherapy. 
Comparisons between groups were analyzed with t tests and Chi-squared tests, interrater 
reliability was assessed with a Cronbach’s alpha coefficient of 0.94 and statistical significance 
was deemed to be p ≤ 0.05. The authors found that the mean scores of PONV were significantly 
lower for the intervention group than the control group (p < 0.001). Additionally, the interaction 
between group and time was statistically significant (p < 0.001) meaning that the changes in 
mean PONV scores between the groups was significantly different over time with the 
intervention group experiencing a faster decline in PONV scores. Finally, mean PONV scores 
were significantly lower for the intervention group than control group at six hours, 12 hours and 
24 hours postoperatively (p < 0.05). While the authors conclude that inhaled ginger essential oil 
as aromatherapy is effective at reducing PONV in patients undergoing major abdominal surgery 
and is promising for PONV in general, they make sure to note that it is unknown at what time the 
beneficial effects of the intervention took place within the first six hours. The authors also 
include that it is impossible to blind both participants and researchers because the nature of the 
intervention is scent. The authors also assert that larger samples sizes in future research are 
needed and that this article did not evaluate the effectiveness of ginger essential oil aromatherapy 
while in the PACU. For the aforementioned reasons, the results of this study should be 
interpreted with caution. 
Inhaled Peppermint Oil for Postop Nausea in Patients Undergoing Cardiac Surgery 
 Briggs, Hawrylack and Mooney (2016) assert that not only is PONV an unpleasant event 
for many patients but that it has special importance for cardiac patients’ as the antiemetic of 
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choice for cardiovascular critical care complex (CVCCC), ondansetron, has a tendency to make 
patients drowsy and interfere with their compliance in ambulation and deep breathing exercises 
and has been reported to cause dysrhythmias. The authors of this study conducted a quasi-
experimental study with no control and the intervention of a peppermint oil nasal inhaler with 
level of evidence of III.  The purpose of this study was to determine how effective peppermint oil 
is in managing PONV in cardiac patients and to determine the level of patient satisfaction of 
management of PONV with peppermint oil. A power analysis was conducted and determined 
need of 30 participants to yield results of statistical significance of p ≤ 0.05. In the end, 123 
patients were enrolled through convenience sampling that was conducted in a large tertiary care 
and academic facility in Delaware on the step-down unit. Thirty-four participants were included 
in the study group after developing PONV and of those 34, only 30 completed the exit 
questionnaire. Included in those enrolled, were adult cardiac surgery patients who underwent 
implantable electronic lead revision, coronary artery bypass (CAD), thoracic aortic aneurysm 
repair, valve surgery, transcatheter aortic valve replacement and left-ventricular assist device 
implantation surgeries. Inclusion criteria for the study consisted of being at least 18 years old, 
being willing to try aromatherapy and being able to speak and understand English. Exclusion 
criteria for this study included having allergies to alcohol based products or peppermint and not 
being able to provide informed consent. One nurse prepared all inhalers independently which 
consisted of three drops of peppermint essential oil on a cotton wick. Each inhaler had a cap on 
both ends, four holes at the base of the inhaler and one opening at the other end used for 
inhalation through one naris. Upon the patient’s first presentation of nausea, they were asked to 
self-report their level of nausea on a scale of zero to five with zero being “no nausea” and five 
being “nausea with dry heaves reported” (Briggs et al., 2016). The nurse then provided teaching 
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on the use of the inhaler which included holding inhaler up to the patient’s naris of choice, 
closure of the other naris with fingers, inhalation for three seconds, holding of the breath for 
three seconds and exhalation through pursed lips for three seconds repeated a total of three times. 
Following the intervention, the nurse would then ask the patient to again report their nausea on 
the zero to five scale two minutes after the first report of nausea (Briggs et al., 2016). Following 
the protocol, participants were asked to report their level of satisfaction of the management of 
PONV from “not satisfied” to “very satisfied” on a scale of zero to ten, their willingness to try 
the protocol again in the future, and if they thought that peppermint oil should be used to treat 
PONV. Data was analyzed with Statistical Package for the Social Sciences (SPSS) software. 
Comparative t tests were used to compare pre-intervention and post-intervention scores. The 
authors found that the difference in mean nausea scores before and after using peppermint 
inhalers was significant (p = 0.05) with the post-use scores being lower. Additionally, 93% of 
participants who answered the exit survey reported being satisfied with management of PONV in 
this study and would be willing to try it again, and 90% of the participants who answered the exit 
survey reported that they thought peppermint oil should be one of the options presented for 
management of PONV. The authors state that their findings are consistent with other studies 
regarding the use of postoperative nausea (PON) and that peppermint oil and that peppermint oil 
aromatherapy is a cost-effective way to manage PONV and should be used routinely. The 
authors also note that further research is needed to identify the effect of peppermint oil on 
patients with gastrointestinal disorders. This study had several limitations including the use of 
multiple nurses in data collection and only using patients in the step-down unit as opposed to 
including patients in the intensive care unit (ICU). Additionally, this study would benefit from 
use of more study participants because a large portion of those originally enrolled did not present 
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PONV and therefore did not receive the intervention. The nurse teaching the intervention to the 
patient did not assess the patency of the nares before allowing the patient to choose which naris 
to inhale from which may have affected the absorption of the peppermint. Finally, there was no 
control or randomization in this study which greatly decrease the level of evidence. Because the 
results of this study were not comparative, it may have limited the generalizability of the results 
of the study. 
Controlled Breathing With or Without Peppermint Aromatherapy for Postoperative 
Nausea and/or Vomiting Symptom Relief: A Randomized Controlled Trial 
 Sites et al. (2014) noted that much of what is known about aromatherapy for medical 
purposes is anecdotal but is also one of the three interventions contained in the ASPAN guideline 
for PONV management. For these reasons, the authors conducted a randomized control trial with 
a level of evidence of II to determine the efficacy of controlled breathing (CB) in conjunction 
with peppermint aromatherapy compared to a control group of CB alone on the effects of the 
symptoms of PONV. The setting for this study was a rural, non-profit hospital in North Carolina, 
USA, in the PACU, operative suite and surgery units. The authors conducted a power analysis 
and determined the need for 130 total subjects to be enrolled to achieve results of statistical 
significance of p ≤ 0.05. Convenience sampling was used and a total of 330 subjects were 
selected with participants randomized by a computer generated program yielding 161 
participants in control CB group, and 169 patients in the aromatherapy group. Because there 
were high levels of certified registered nurse anesthetist (CRNA) unavailability, high levels of 
attrition, and not all participants experienced PONV, only 16 participants in the CB control 
group and 26 participants in the CB with aromatherapy group produced data that could be 
analyzed. Inclusion criteria consisted of the ability to breathe through the nose, being 18 years or 
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older, being able to verbalize incidences of nausea and vomiting and participants were scheduled 
to receive ENT, orthopedic, urologic or laparoscopic surgeries under general anesthesia. 
Exclusion criteria included being nauseous or vomiting within 24 hours of surgery, having a 
history of menthol or peppermint allergies, having a history of alcoholism, being pregnant, being 
a patient from the department of corrections, having emergent surgeries over the weekend 
preceding the study or taking metronidazole or disulfiram. Participants were asked to describe 
the current nausea and vomiting on a zero to 10 descriptive ordinal scale (DOS) before surgery 
with zero being “none” and 10 being “the worst symptoms a subject could imagine” (Sites et al., 
2014). Subjects each received a 13-dram vial with a cotton braid to hold under their nose during 
deep breathing with the control group not having anything on the cotton braid and the 
aromatherapy group having 500 mL of peppermint spirits applied to the cotton braid. Participants 
were instructed to deeply inhale through the nose for three seconds, hold their breath for three 
seconds, and exhale for three seconds repeating this for a total of three breaths after the initial 
presentation of PONV. PONV was assessed five minutes after the initial episode on the DOS and 
if symptoms remained, the intervention and assessment were completed once more. If the 
symptoms still remained after repetition of intervention, the patient was offered a rescue 
antiemetic. Data was collected on DOS scores, types of medications both intraoperatively and 
postoperatively, time on NPO, risk factors and demographics. Data was analyzed with standard 
deviations, frequencies and means as well as Chi-squared tests for categorical data. There were 
not statistically significant differences between groups in demographic data including gender and 
age. Out of the risk factors analyzed, being of female gender was the only statistically significant 
predictor of developing PONV (p = 0.0024). The authors found that as the number of risk factors 
for PONV increased from two to three to four, the incidence of PONV increased from 14%, 32% 
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to 83% respectively. The need for antiemetic therapy was similar between groups (p = 0.76) as 
was the effectiveness of intervention (p = 0.61). The authors conclude that peppermint 
aromatherapy used with CB is effective at controlling PONV symptoms, however it may not be 
more effective than CB alone. While these findings are clinically relevant, in order to comment 
with certainty there is need for future research. In the meantime, CB should be used 
perioperatively to reduce PONV symptoms as it can be initiated at the bedside at minimal cost to 
the facility. As mentioned previously, the study suffered from high attrition rates and CRNA 
unavailability requiring exclusion of several eligible participants. For these reasons the study did 
not yield statistically significant results and caused validity to decrease. Additionally, the authors 
state that this study solely evaluated the effectiveness on a single episode of PONV and not 
throughout the entire post-operative period. For various reasons, the results may not be of high 
quality and therefore may not be generalizable to larger populations or be clinically applicable. 
Effects of Controlled Breathing, With or Without Aromatherapy, in the Treatment of 
Postoperative Nausea 
 Cronin et al. (2015) recognized that though there was some research indicating the 
positive effects of aromatherapy on PONV, few studies have been completed regarding isopropyl 
alcohol (IPA). Because of this lack of research, the authors conducted a study to compare the 
effectiveness of CB with and without inhaled IPA for management of postoperative nausea 
(PON) in adult female patients undergoing outpatient laparoscopy procedures. The design of this 
study was that of a quasi-experimental randomized two group study with a level of evidence of 
III in which the control consisted of CB alone and the treatment consisted of CB with inhaled 
IPA. The authors used convenience sampling in a community hospital’s outpatient surgery center 
in the United States. A power analysis was conducted and determined the need for 100 
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participants with 50 participants in each group to yield results of statistical significance of p = 
0.05. In the end, 41 patients were included in both control and treatment groups. Inclusion 
criteria included being a female patient between of 18 and 60 years old, and having outpatient 
laparoscopic surgery under general anesthesia with an endotracheal tube or laryngeal mask 
airway. Exclusion criteria for this study included having nausea prior to administration of 
anesthesia, having allergies to IPA, the inability to breathe effectively through the nose, not 
being able to read or speak English and finally, having documented Alzheimer’s disease or 
dementia and/or not being able to provide informed consent. Patients were instructed on how to 
slowly inhale through the nose for three breaths and exhale through the mouths and on how to 
use the verbal numeric nausea intensity scale from zero to 10 and upon the first presentation of 
nausea in the PACU. The participants were randomly assigned to control group in odd calendar 
months and the treatment group assigned to even calendar months. The participants were then 
asked to rate their nausea on the scale from zero to 10 and were guided through the CB exercises. 
The treatment group had a gauze pad with IPA on it placed below their nose for inhalation. The 
participants were again asked to rate their nausea two minutes later and if symptoms remained, 
the participants were able to choose between repeating the same procedure or using rescue 
antiemetics. Scores on the verbal numeric nausea scale were again collected three minutes later if 
participants repeated the procedure and participants were once again allowed to choose between 
repeating the procedure and rescue antiemetics if symptoms continued to persist. The authors did 
not disclose how data analysis was conducted which was a major limitation of the study. The 
authors found that the data between groups regarding time spent in surgery, type of surgery, 
history of nausea or vomiting, and amount of fluids were similar except for data regarding age 
which was significantly higher in the treatment group (p = 0.03) and history of smoking which 
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was significantly higher in the control group (p =0.04). Similarly to how nausea scores decreased 
significantly over time in both treatment and control groups (p < 0.001), the number of 
participants requesting rescue antiemetic medication did not differ significantly from treatment 
to control groups at two minutes (p = 0.78), at five minutes (p = 0.48), or overall (p = 0.18). 
Additionally, there were no significant differences in nausea scores between the intervention and 
control groups (p = 0.09). One limitation of this study was that because many of the study 
participants received a variety of antiemetic medication both preoperatively and/or 
intraoperatively, they did not experience PON and were not included in control and treatment 
groups therefore limiting the size of the study. Additionally, the subjects were not blinded and 
therefore it was a quasi-experimental study with a level of evidence of III instead of a 
randomized controlled trial with a level of evidence of II. Though the results need to be 
interpreted with caution, the authors conclude that CB can be used to help control PON and 
should be taught to patients as a first response to PON due to the cost effective nature of the 
intervention with no side effects. The authors also assert that more research is needed to 
definitively conclude that aromatherapy is no more effective than controlled breathing at 
reducing PON. Because this study was conducted in a non-specialized community hospital with 
patients undergoing a variety of laparoscopic procedures, the results may be generalizable to 
larger populations or those undergoing surgeries of similar invasiveness as laparoscopies. 
Despite the generalizability of this study, the results may not be of high quality and therefore 
should be interpreted with caution. 
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Comparison of Inhalation of Isopropyl Alcohol vs Promethazine in the Treatment of 
Postoperative Nausea and Vomiting (PONV) in Patients Identified as at High Risk for 
Developing PONV 
 Pellegrini, DeLoge, Bennet and Kelly (2009) disclose that for patients who are identified 
as having a high risk for developing PONV, prophylactic ondansetron is widely used though it is 
only 25% effective. As a result of the ineffectiveness of ondansetron, promethazine is often used 
to treat breakthrough PONV. Promethazine can cause unpleasant symptoms such as dry mouth 
and sedation and even dangerous side effects such as hypotension. Additionally, providers often 
prescribe oral or suppository forms of promethazine for outpatients and who are often hesitant 
towards these forms of mediations due to the presence of nausea and social stigmas. Because of 
the issues associated with promethazine, the research team conducted a study to determine if 
70% IPA aromatherapy was more beneficial than intravenous (IV) promethazine at treating 
breakthrough PONV in patients identified as high risk who had previously received prophylactic 
ondansetron. The study design was that of a randomized controlled trial with a level of evidence 
of II.  A power analysis was conducted and determined the need for 40 participants in each 
group, however after factoring in a possible attrition rate of 20%, the sample size to increase to 
96 with 48 participants in each group. The researchers used convenience sampling and recruited 
a total of 85 participants with 43 in IPA aromatherapy intervention group and 42 in the 
promethazine control group randomly assigned via computer generation. Inclusion criteria for 
this study included being scheduled for a surgery with anesthesia lasting more than one hour, and 
having at least two of the four risk factors for PONV including being of female gender, a history 
of PONV, a history of motion sickness and/or being a nonsmoker. Exclusion criteria for this 
study included, having recent upper respiratory infections, being pregnant, being unable to 
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breathe through the nose, using psychoactive or antiemetic drugs within the past 24 hours, 
having a body mass index (BMI) of 35 kg/m2 or more, being allergic to metoclopramide, 
promethazine, ondansetron or IPA, or requiring the need for hospitalization not related to PONV. 
The study was conducted in the PACU, the same-day surgery unit (SDSU), and following 
discharge at home in the United States. All participants received 4 mg of IV ondansetron 
prophylactically 15 to 30 minutes before being extubated. The control group received 12.5 to 25 
mg IV promethazine in the PACU and SDSU or used self-administered promethazine 
suppositories after discharge, and the intervention group received 70% inhaled IPA 
aromatherapy as a treatment. After researchers received informed consent, the participants 
preoperatively rated their baseline nausea on a visual numeric rating scale (VNRS) from zero to 
10 with zero being “no nausea” and 10 being “worst imaginable nausea” (Pellegrini et al., 2009).  
Upon arrival in PACU and SDSU, VNRS scores were again recorded for nausea with each 
episodes of nausea being at least one minute from the last at the first patient complaint of nausea. 
VNRS scores were again recorded after the first complaint every five minutes for the first 30 
minutes, and every 15 minutes following that for the following 75 minutes or discharge, 
whichever came sooner. The control group in the PACU and SDSU received IV promethazine 
upon first patient complaint of nausea with the ability to repeat treatment after 30 minutes up to a 
total of 50 mg per patient. If the initial promethazine administration was sufficient to relieve 
PONV symptoms, patients could receive 10 mg IV metoclopramide every 15 minutes with a 
maximum does being 30 mg per patient. Upon discharge, the patients were instructed to use a 25 
mg promethazine suppository every six hours as needed at home. In the intervention group, the 
participants each received 70% IPA pads in paper coverings and were then instructed to remove 
the cover, fold the pad, hold the pad 0.5 inches away from the nares and to take three deep 
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breaths through the nose before throwing away the pad both in the PACU, SDSU and post 
discharge. This protocol was repeated as needed up to three times. Intervention group patients 
also were instructed on the use of 25 mg promethazine suppositories if their PONV symptoms 
were not resolved with IPA aromatherapy. Patients in both groups received paperwork to 
document their VNRS scales at home and instructions on when to collect this information in 
regard to administration of treatments. The participants then reported their VNRS scales on 
telephone calls along with data regarding their satisfaction of their specific antiemetic therapy on 
a scale of one to five with one being “totally dissatisfied” and five being “totally satisfied” 
(Pellegrini et al., 2009). SPSS software was used to statistically analyze the data, Chi-squared 
tests and Pearson correlations were used to analyze frequencies, and VNRS scores were analyzed 
with t tests with p ≤ 0.05 considered to be statistically significant. There were no significant 
differences found in surgery times or demographic data save for the fact that participants in the 
intervention group received significantly more nitrous oxide (p = 0.049) than the control group. 
Follow up statistical analyses were conducted and the amount of nitrous oxide administered did 
not show statistically significant effects in increasing risk of PONV. The authors found no 
significant differences between control and intervention group in incidence of nausea until 
discharge. The intervention group experienced a faster decline in VNRS scores of nausea than 
control group in the, SDSU (p = 0.032), PACU (p = 0.045) and at home (p = 0.017). 
Significantly more participants in the control group used their promethazine suppository as a 
rescue antiemetic at home compared to the number who used inhaled IPA at home (p = 0.039). 
The authors admit that there were limitations to their study including that the number of 
participants were limited because the methods of data collection were intensive and time 
consuming and therefore limited the number of participants to one to two per day. Additionally, 
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the data regarding rescue antiemetic medication at home, specifically promethazine, may be 
influenced as there may be a social stigma concerning rectal suppositories. In the end, the 
authors conclude that participants in the intervention group experienced less side effects from 
IPA than those in control group from promethazine. Additionally, IPA is as effective as 
promethazine for treatment of PONV in patients identified as being high risk for developing 
PONV and is more cost effective, easy to administer and works faster than promethazine. 
Despite the relatively small sample size, the study was conducted with a high level of evidence, 
in a broad population and yielded results of statistically significant indicating generalizability 
and applicability of results. 
Aromatherapy for Treatment of Postoperative Nausea and Vomiting (Review) 
 Hines, Steels, Chang and Gibbons (2018) updated a systematic review with a level of 
evidence of I originally published in 2012 under The Cochrane Collaboration. The purpose of the 
review was to establish both the safety and efficacy of aromatherapy compared to standard 
pharmacotherapy for PONV severity and duration in both children and adults. A variety of 
databases were searched including MEDLINE, CINAHL EmBase, CENTRAL, PubMed, ISI 
Web of Science, Informit and LILACS for articles published until March of 2017. Search criteria 
included all clinical controlled trials (CCTs) and randomized controlled trials (RCTs) in which 
aromatherapy was used a treatment for PONV with primary outcomes being PONV duration and 
severity and secondary outcomes being use of rescue antiemetics, adverse reactions and patients’ 
satisfaction. Two of the four authors read titles and abstracts of articles to determine relevance of 
full text articles and translated articles that were potentially relevant and not in English. Three 
authors compared those articles with inclusion criteria via a standardized checklist for the 
review. Following the review for inclusion criteria, two authors extracted data using Plot 
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Digitizer software. Risk of bias was assessed by two authors with a third author settling any 
disputes using a Cochrane tool for characteristics including blinding, randomization, allocation 
concealment, selective reporting and incomplete data. In total, 16 studies were included in the 
review including 5 CCTs and 11 RCTs with a total of 1036 participants. Articles were assessed 
for quality using the GRADE approach and the studies included were found range between very 
low quality and moderate quality. A risk ratio (RR) was used to compare dichotomous data with 
95% confidence intervals (CI) and a standardized mean difference (SMD) was used to analyze 
continuous variables. The authors found that compared to a placebo, aromatherapy was not 
effective in reducing the severity of PON (p = 0.28) or was significantly related to the likelihood 
of absence of PON at the end of the treatment period (p = 0.33). Additionally, peppermint 
aromatherapy compared to placebo was not effective at reducing PON (p = 0.59).  Compared to 
the placebo, those in the aromatherapy group were significantly less likely to need to use rescue 
antiemetic medications (p = 0.04). IPA aromatherapy was found to be beneficial as compared to 
standard antiemetic therapy as the IPA aromatherapy group showed significantly quicker times 
to reach 50% reduction in PON (p < 0.00001) Also the IPA aromatherapy group patients were 
significantly less likely to require rescue antiemetic medication than the control group patients (p 
= 0.04). Although IPA aromatherapy reduced the time to reach a reduction in PON, it did not 
produce significantly fewer instances of need for rescue antiemetic compared to standard 
antiemetics (p = 0.11). In conclusion, the authors assert that low quality evidence suggests that 
those using aromatherapy may require less rescue antiemetic therapy and may have a similar 
effect as placebo on eliminating nausea. Because the results of this study are based off of quality 
including very low quality data, the results may not be accurate or generalizable and there 
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remains need for further studies of high quality evidence regarding the use of aromatherapy for 
prevention and treatment of PONV.  
Acupuncture of Pericardium 6 Acupressure Point 
Comparison Between Effects of Acupuncture and Metoclopramide on Postoperative 
Nausea and Vomiting after Gynaecological Laparoscopy: A Randomized Controlled Trial 
Albooghobeish et al. (2017) assert that common drugs used to alleviated PONV such as 
metoclopramide and ondansetron often have significant side effects including hypotension, 
drowsiness and extrapyramidal symptoms (EPS) and an alternative treatment of acupoint 
stimulation has minor side-effects and is minimally invasive. Despite these facts, there has been 
little research comparing the effects of traditional pharmacotherapy with acupuncture of point P6 
in relation to PONV. This double-blinded, randomized controlled trial with a level of evidence of 
II was conducted in order to compare the effect acupuncture and metoclopramide for PONV in 
gynecologic laparoscopic surgeries. A power analysis was conducted and determined the need 
for 36 participants in each of the three study groups in order to yield results of statistical 
significance. The control group received IV normal saline, the intervention group received IV 
metoclopramide, and a second intervention group received P6 acupuncture. The study was 
conducted in a general hospital in Ahvaz, Iran, with patients who were selected through 
convenience sampling. In the end, there were a total of 41 participants in the control group, 40 
participants in the P6 acupuncture group and 41 participants in the metoclopramide group who 
were randomized via computer generation. Inclusion criteria for this study included being a 
patient undergoing gynecologic laparotomy, being of ASA status I, and being between 19 and 46 
years or age. Exclusion criteria for this study included having a history of smoking, having a 
history motion sickness, having a history of ear or gastrointestinal disorders that can cause 
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vomiting and nausea, having a BMI of 30 kg/m2 or higher, taking any antihistamine or antiemetic 
medication within 24 hours of surgery, experiencing nausea and vomiting a week or less before 
surgery, taking drugs that may cause EPS and having any scarring or infections at the site of 
acupuncture. Acupuncture was done with a sterile needle with a diameter of 0.25 mm and a 
length of 25 mm. The needle was inserted at a depth of five to seven mm at the P6 acupoint 
directly after anesthesia induction. The need was removed before extubation and before transfer 
of patient to recovery. Patients in the metoclopramide group received 0.2 mg/kg IV 
metoclopramide directly after anesthesia induction. The control group received 1.0 mL of IV 
normal saline directly after anesthesia induction with the administration of fluids terminated 
before extubation. The examiners of PONV were anesthesia assistants that were different from 
anyone who completed the intervention and therefore were not biased in their examination and 
data collection of PONV symptoms. All patients were given 10 mg IV metoclopramide if they 
vomited and all received a suppository of 100 mg sodium diclofenac for analgesia. Data on 
vomiting and nausea occurrences were collected in the form of observation by the anesthesia 
assistant and questioning of the patient both one and two hours postoperatively. The 
demographic data was analyzed with mean, standard deviation and descriptive statistics. The 
incidence of nausea and vomiting were reported as both percentages and frequencies. 
Comparative data was analyzed with Chi-squared and Fisher’s tests with a statistical significance 
set at p ≤ 0.05. The authors found no statistically significant differences in demographic groups 
but did find that the incidence of PON and postoperative vomiting (POV) one and two hours 
after surgery was lowest for the acupuncture group. Additionally, one hour after surgery, the 
acupuncture group experienced significantly lower incidences of PON compared to 
metoclopramide group (p = 0.027). The acupuncture group compared to control group 
INTEGRATIVE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING: A 
BEST PRACTICE APPROACH  
29 
experienced significantly fewer episodes of PON one hour after surgery (p = 0.015), two hours 
after surgery (p = 0.002), and POV two hours after surgery (p = 0.011). The metoclopramide 
group compared to control group experienced significantly fewer incidences of POV two hours 
after surgery (p = 0.046). The authors concluded that acupuncture of P6 is more effective than no 
intervention for reducing PONV and may be more effective than metoclopramide intervention 
for reducing PONV. Additionally, P6 acupuncture reduces the need for antiemetic medication 
and PONV in gynecologic laparoscopies. The authors concede that their short follow up time 
may have confused the results of the study and that studies following late onset PONV may be 
necessary to better generalize the results. Though this study was conducted very well, it may not 
be generalizable to a larger population as it was conducted with a very specific population of 
women receiving gynecological laparoscopic operations.  
Comparison of the Wrist Acupuncture Point P6 with Pharmacologic Management to 
Prevent Postoperative Nausea and Vomiting in Patients Under Laparotomy: A Double 
Blind Study 
 Bakhshaei, Khoshraftar, Shoja and Mehrabi (2018) note that when taking into account the 
cost-benefit analysis of alternative therapies to manage and prevent PONV, alternative therapies 
are becoming more enticing compared to traditional pharmacotherapies. In this double- blind 
randomized control trial with a level of evidence of II, the authors set out to determine the 
effectiveness of wrist acupuncture compared to traditional medication for management of PONV 
in patients undergoing laparotomies. The authors did not mention use of power analysis to 
determine sample size, however it is stated that 100 participants were recruited through 
convenience sampling to yield a total of 50 participants in both the control of standardized 
medications and intervention group of wrist acupuncture. Inclusion criteria for this study 
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included being between 18 and 70 years of age, being a candidate for an elective laparotomy, 
being ASA status I or II, having no history of PONV, being under general anesthesia, not using 
antiemetics within the 24 hours prior to surgery, and the signing of an informed consent. 
Exclusion criteria for this study included dependencies on drugs or alcohol, the use of opium, the 
presence of wounds or scarring at acupuncture site, not being 18 to 70 years old, having a history 
of psychological or neurological disorders, undergoing surgery lasting longer than two hours, 
having a history of disorders precipitating nausea and vomiting, being pregnant, vomiting or 
becoming nauseous 24 hours prior to surgery, those refusing acupuncture, or those receiving 
chemotherapy in the past seven days. All 100 participants were randomized with computer 
generated “balanced block randomization” (Bakhshaei et al., 2018). The control group received a 
combination of metoclopramide with dexamethasone with unknown doses or timings with the 
participants being blinded to the treatment. Those in the acupuncture group perceived bilateral 
P6 acupuncture 30 minutes before the conclusion of surgery and were blinded to the treatment as 
well. The site of acupuncture was cleaned with 75% IPA, disposable sterile needles with a 
diameter of 0.25 mm and length of 25 mm were inserted perpendicularly to the skin until they 
reached a depth of 10 mm at the P6 acupoints. Upon insertion, the needles were pushed 
downward, lifted upward and twirled. An independent nurse collected data regarding 
demographics, duration of anesthesia, duration of surgery, preoperative data and duration of 
endotracheal intubation. An independent observer blinded to the interventions recorded 
postoperative data for the 24 hours following surgery including satisfaction of patient with 
PONV management, need for and use of rescue antiemetics, episodes of nausea with the patient 
reporting on a VAS from zero to 10 with zero being “no nausea at all” and 10 being “worst 
imaginable nausea” and episodes of vomiting assessed by the observer after reporting by the 
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patient (Bakhshaei et al., 2018). Data analysis was conducted with quantitative variables 
analyzed in the form of percentages and frequencies, continuous variables analyzed using t tests, 
and categorical variables analyzed with Chi-squared and Fisher’s tests. Statistical significance 
was determined to be p ≤ 0.05. The authors found that mean recovery times were not 
significantly different between the control and intervention groups nor was prevalence of PONV. 
The authors concluded that P6 wrist acupuncture could be of similar effectiveness to 
metoclopramide with dexamethasone for prevention of PONV and that P6 wrist acupuncture 
may be more desirable than pharmacologic antiemetic medication due to the side effects and cost 
associated with the medications. While these results are clinically significant, it is important to 
note that because the researchers did not disclose the specific intervention information regarding 
metoclopramide and dexamethasone pharmacotherapy, the readers do not have a clear 
understanding as to what medication regimen P6 acupuncture is similar or comparable to. 
Additionally, while the findings presented in this study are consistent with findings published in 
other articles, the interventions were tested on a relatively small group of patients undergoing 
elective laparotomies and may not be generalizable to larger populations. 
The Effect of Acupuncture on Postoperative Nausea and Vomiting after Pediatric 
Tonsillectomy: A Meta-Analysis and Systematic Review 
 Shin et al. (2016) published a systematic review and meta-analysis with a level of 
evidence of I in The Laryngoscope, the official publication of The American Laryngological, 
Rhinological and Otological Society. The purpose of this review was to determine the antiemetic 
efficacy of acupuncture following pediatric tonsillectomies. A total of seven authors published 
the study with smaller numbers of researchers conducting different portions of the review. For 
example, two of the researchers independently searched databases including EmBase, 
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MEDLINE, and Cochrane databases for articles including keywords “tonsillectomy,” “child,” 
“acupuncture,” “acupuncture therapy,” and “vomiting” that were published before July of 2015. 
To be included in the review articles had to be full length and original, and either a retrospective 
or prospective trial or a RCT. Exclusion criteria for the articles in this review included not 
having a control group, being published in any language other than English, inclusion of adults 
in the sample, having 10 or less cases of PONV, or if the study was not related to 
tonsillectomies. The authors screened the titles and abstracts of articles to determine relevance 
and compliance with inclusion and exclusion criteria and yielded a total of eight studies. The 
studies included in the review included four RCTs, three prospective cohort studies, and one 
pilot study yielding a total of 800 subjects with 406 subjects in the control group of no treatment 
or classic antiemetic treatment. and 394 subjects included in the acupuncture intervention group. 
All acupuncture therapies included in this study included either bilateral or unilateral 
acupuncture of the P6 acupoint. RRs were used to represent effect size with a 95% CI, standard 
errors were calculated, and a Cochrane Review Manager was used to analyze and display data 
statistically. Subgroup analyses were conducted regarding both methodology and modality. 
Publication bias was analyzed and represented on a funnel plot, and if found, was corrected with 
“Duval’s trim-and-fill method” (Shin et al., 2016). A sub method for correcting publication bias 
was used on one cohort study that was unpublished at the time the review was conducted. 
Though the authors do not state how the articles were assessed for quality, they do state that the 
eligible studies ranged from high quality to moderate quality. The authors found that the 
incidence of PONV was significantly reduced for acupuncture interventions compared to control 
by 23% with a relative risk ratio of 0.77 (p < 0.05). Additionally, electrostimulation interventions 
had a significantly lower RR than that of traditional acupuncture (0.59 compared to 0.87) (p < 
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0.05). Finally, the RR from randomized controlled trials was lower than that of the prospective 
cohort studies (0.74 compared to 0.83) though it was not statistically significant. The researchers 
admit that there was an outlier in one study, though the omission of the outlier did not alter the 
results of the risk ratio (0.787 compared to 0.77) and the outlier may have occurred due to the 
specific method of electrostimulation used which may have had a greater effect on PONV than 
the other studies. Shin et al. (2016) conclude that acupuncture is an effective form of alternative 
antiemetic therapy to reduce PONV after pediatric tonsillectomies. While the researchers do not 
state if their results are consistent with previous findings, they appear confident that with further 
research, acupuncture could improve patient outcomes and experiences.  
The Effectiveness of Acupuncture in Prevention and Treatment of Postoperative Nausea 
and Vomiting – A Systematic Review and Meta-Analysis 
 Cheong, Zhang, Huang and Zhang (2013) conducted a systematic review and meta-
analysis with a level of evidence of I originally published by PLoS ONE in order to determine 
the efficacy of multiple acupuncture treatments and of acupoint selections on treating and 
preventing PONV. While acupoint selection and type of acupuncture were the primary outcomes 
being looked at, secondary outcomes included side effects, use of rescue antiemetics, optimal 
timing of intervention, and techniques used in interventions. The researchers searched EBSCO, 
Cochrane Controlled Trials Registry, OVID, PubMed, Wanfangdata and CNKI for terms 
including “nausea and vomiting,” “postoperative,” “acupoints,” “acupressure,” “acupuncture,” 
“electroacustimulation,” “transcutaneous electric nerve stimulation,” “electro-acupuncture,” 
“electrical acupoint stimulation,” “electrical acustimulation,” “auricular acupuncture,” “sticking 
therapy,” “warm need therapy,” “moxibustion,” and “moxa” published up to July of 2013. 
Search criteria included RCTs, any form of acupuncture, participants who underwent some kind 
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of surgery, and results collected form publications between 1986 and 2013. Exclusion criteria for 
this review included trials that were not randomized, patients who experienced nausea and 
vomiting preoperatively, those with chronic or co-existing conditions, patients who used 
antiemetics preoperatively, articles not originally published in Chinese or English, and articles 
that did not include detailed protocol descriptions. The evaluation of the articles for inclusion 
was performed by two of the four authors with a third author resolving any discrepancies or 
disputes. Within this review, the control was considered to be sham interventions, standard care 
protocols, counseling and/or medication while the intervention was considered to be any type of 
acupuncture including acupressure, manual acupuncture, electrical acupoint stimulation, and 
combinations of techniques. A total of 30 RCTs were included in the review with a total of 1,276 
participants in the control group and 1,258 participants included in the acupuncture intervention 
group. Data was compiled in a Microsoft Excel document and analyzed with a fixed-effects 
model, and RRs with 95% Cis.  p < 0.05 was considered to be statistically significant and risk of 
bias was assessed with funnel plots. Included studies were assessed for quality using the GRADE 
method scoring each article as high quality, moderate quality, low quality or very low quality. 
The researchers found that PC6 acupuncture significantly reduced overall incidences of PON 
zero to 24 hours (p = 0.002) but not early PON within zero to six hours. Similarly, PC6 
acupuncture significantly reduced incidences of early POV zero to six hours (p = 0.003) but not 
for overall vomiting zero to 24 hours. PC6 acupressure was found to significantly reduce 
incidences of PON zero to 24 hours (p = 0.001) and POV zero to 24 hours (p = 0.000) compared 
to the sham intervention groups. Additionally, PC6 electro-acupoint stimulation significantly 
reduced incidences of PON zero to 24 hours (p < 0.000) and POV zero to 24 hours (p < 0.000) 
compared to the sham intervention group. Finally, PC6 stimulation combined with other 
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acupoints significantly reduced incidences of PONV zero to 24 hours (p = 0.001) POV zero to 24 
hours (p = 0.000) and PON zero to 24 hours (p = 0.000) compared to the control groups. The 
authors site several articles and previous reviews that produced similar results regarding the 
efficacy of P6 acupuncture for prevention of PONV. Out of the studies regarding P6 acupoint 
included in this study, four were of high quality, nine were of moderate quality and three were of 
low quality. Though the studies regarding P6 were solely focused on prevention and not 
treatment of PONV, the timing of the acupuncture interventions varied, and the durations of the 
acupuncture interventions varied, there is still strong evidence that acupuncture of the P6 
acupoint can effectively prevent PONV. P6 acupuncture is both safe and cost effective, and the 
results of this study are clinically relevant and applicable for both treating and preventing PONV. 
Stimulation of the Wrist Acupuncture Point PC6 for Preventing Postoperative Nausea and 
Vomiting (Review) 
 Lee, Chan and Fan (2015) updated a systematic review with a level of evidence of I 
originally published in 2004 for the Cochrane Collaboration. The purpose of the review was to 
determine both the safety and efficacy of stimulation of the P6 acupoint either in combination 
with antiemetic drugs or alone compared to antiemetic drugs or sham interventions in the 
prevention of PONV in surgery patients. Databases searched included MEDLINE, ISI Web of 
Science, EmBase, Cochrane Central Register of Controlled Trials, World Health Organization 
Clinical Trials Registry and ClinicalTrials.gov. Search terms included “nausea and vomiting,” 
“postoperative complications,” “acupuncture therapy,” “acupuncture,” “transcutaneous eclectic 
nerve stimulation,” “electro-acupuncture,” and “acupressure” (Lee et al., 2015). Search criteria 
included randomized trials involving P6 acupoint stimulation in comparison with medications or 
sham treatments, or combination of medication with P6 stimulation compared to medications 
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alone for PONV prevention. The primary outcome of this review was PONV incidence and 
secondary outcomes were adverse effects of treatment and need for rescue antiemetic 
medications. Titles and abstracts of all studies accumulated in the search were screened for 
compliance with inclusion criteria by two researchers with a third settling disputes or 
discrepancies. Risk for bias was assessed using Cochrane guidelines from low risk of bias to high 
risk of bias and articles were assessed for quality using the GRADE approach ranging from high 
to very low qualities of studies.  In total, 59 RCTs were included in this review with a total of 
7,667 patients in all studies. A random effects model was used to analyze the data and reported 
as RRs with a 95% CI. Trial sequential analysis (TSA) was conducted to inform the required size 
of information for a 30% reduction of RR. The authors found that P6 acupoint stimulation 
significantly reduced the incidence of PON, POV and need for rescue antiemetic drugs. It was 
also found that P6 acupoint stimulation did not significantly reduce the incidence of PON, POV 
or need for rescue antiemetic drugs when compared to six different antiemetic drugs.  
Combination of antiemetic drugs with P6 acupoint stimulation reduced POV and did not reduce 
PON or the need for rescue antiemetic drugs. The P6 acupoint stimulation group in combination 
with antiemetic drug therapy compared to antiemetic drug therapy alone needed less rescue 
antiemetic drugs. While in one study a participant was not blinded, in two studies the providers 
were not blinded, in three studies the assessors were not blinded, in three studies there were 
attrition rates and the interventions included were not solely limited to P6 acupoints, the quality 
of evidence is moderate. The authors conclude that, P6 acupoint stimulation is a worthwhile 
intervention for those at high risk for developing PONV due to the minor adverse effects and 
may be considered an alternative antiemetic treatment for certain patients. This study is clinically 
applicable, generalizable, and it is clear that the information from this review can both improve 
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experiences of care as well as the outcomes of patients undergoing surgery and experiencing 
PONV.  
Supplemental Inspired Oxygen 
Effects of High Intraoperative Inspired Oxygen on Postoperative Nausea and Vomiting in 
Gynecologic Laparoscopic Surgery 
 Simurina et al. (2010) assert that there is very little data regarding the use of 0.5 FIO2 on 
early and late postoperative PONV. Because of this, the authors set out to test their hypothesis 
that high intraoperative FIO2 of 0.5 and 0.8 compared to the 0.3 FIO2 used routinely would 
reduce PONV in the first 24 hours in women recovering from elective gynecologic laparoscopies 
under general anesthesia. This study was a RCT with a level of evidence of II. The settings for 
this study was the PACU and gynecologic floor of a general hospital in Zadar, Croatia. A power 
analysis was conducted and determined the need for 37 participants in each group to yield “80% 
power for detecting a 50% reduction in the frequency of PONV” and an 𝛼 of 0.05 (Simurina et 
al., 2010). Convenience sampling was used and a total of 36 patients were included in each of the 
three groups; one receiving FIO2 of 0.3, one receiving FIO2 of 0.5 and one receiving FIO2 of 0.8. 
Inclusion criteria was defined as patients of ASA class I or II, provision of informed consent, 
being an adult, and receiving elective gynecological laparoscopies. Exclusion criteria for this 
study included having a BMI of 30 kg/m2 or more, being pregnant, breastfeeding, having a 
pulmonary disease, having a disease that could impair gastric motility, having known 
hypersensitivities to medications, using antiemetics, hormones, steroids or psychotropic drugs 
within three days of surgery, having a history of migraines, having renal impair, having a history 
of vestibular diseases, patients with irregular menstrual cycles, patients with injury to the central 
nervous system or having dependence on alcohol or opioids. Additionally, participants were 
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excluded from the study after enrollment if they developed intraoperative complications such as 
severe hypotension, drug hypersensitivities, excessive blood loss, intubation difficulties, or 
preoperative hypoxia those who developed complications postoperatively. A total of 40 
participants were randomized to each of the three treatment groups via randomized computer 
generation, however four participants were excluded from each group due to a variety of reasons. 
All study participants were given 7.5 mg oral midazolam one hour preoperatively, did not 
receive prophylactic antiemetics, were given the same anesthesia, were all ventilated with FIO2 
1.0 for three minutes prior to being intubated, were given 10 mL/kg/hr of IV crystalloids and 
were ventilated with 0.3, 0.5, or 0.8 FIO2. Data was collected on frequency of use of rescue 
antiemetics, PON and POV at two hours and 24 hours postoperatively. Nurses trained on the 
study and blinded to the interventions of each patient used a VAS to analyze the PON and pain 
of patients from zero to 100 with zero being “no pain/nausea” and 100 being “maximal 
pain/nausea” (Simurina et al., 2010). The highest score reported in the first two hours and the 
highest score in the two to 24-hour time period were used for analysis of data. Quantitative data 
including episodes of vomiting, VAS scores, risk scores and demographic data were analyzed 
with ANOVA. Categorical data was analyzed using Chi-squared tests and t tests. All confidence 
intervals were 95%, and statistical significance was considered to be p < 0.05. The authors found 
that compared to 30% oxygen, patients receiving 80% oxygen experienced significantly fewer 
episodes of early POV (p = 0.0028). Additionally, patients with supplemental oxygen of either 
50% or 80% experienced fewer episodes of vomiting (p = 0.010). The authors conclude that high 
inspired oxygen does not reduce PONV but does reduce early POV and that high inspired 
oxygen has limited use and should not be recommended for routine PONV prevention. The 
authors admit that because the number of participants was lower than the power analysis 
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indicated there should be, there may be risk of type 1 statistical error which results in a false 
positive. Because of the small sample size, the results must be interpreted with caution and may 
not have clinical applicability.  
Effect of Supplemental Oxygen 80 % on Post-Tonsillectomy Nausea and Vomiting: A 
Randomized Controlled Trial 
Izadi, Delavar, Yarmohammadi, Daneshmandan, and Sadrameli (2016) state that 
supplemental oxygen has been shown to prevent PONV however there is no consensus on what 
types of surgeries and what amounts of oxygen this is true for. Because of this lack of consensus, 
the authors conducted a randomized controlled trial with a level of evidence of II to test the 
hypothesis that PONV in pediatric patients undergoing tonsillectomies can be reduced in the first 
24 hours postoperatively through use of 80% supplemental oxygen. The setting for this study 
was a hospital in Tehran, Iran. A power analysis was conducted and determined the need for a 
sample size of 46 participants in each group. In order to allow for small amounts of attrition, 51 
participants were recruited through convenience sampling and were randomized using computer 
based software to each group. Patients were included in the study if they were between five and 
15 years old, were undergoing tonsillectomies and their parents provided informed consent. 
Exclusion criteria for this study included having any comorbidities that may have influenced 
PONV such as gastroesophageal reflux disease (GERD), anemia, diabetes mellitus (DM), 
immune deficiencies or kidney disease, anyone using antiemetics or those with craniofacial 
abnormalities. Participants were further excluded if they were difficult to intubate, developed 
allergies to the drugs being used, or if they needed additional analgesia or opioids. All 
participants received the same method of anesthesia, the same preoperative medications, the 
same IV solutions, and same methods of intubation with the only difference in treatment being 
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the amount of inspired oxygen either intraoperatively with routine 30% oxygen or high inspired 
oxygen of 80%.  Three trained nurses who were blinded to the amount of intraoperative oxygen 
collected data on the frequency of PONV zero to two hours postoperatively, between hours two 
and six postoperatively, and between six and 24 hours postoperatively. SPSS software was used 
to analyze the data with results considered to be statistically significant at p < 0.05. The authors 
found that the incidence of nausea and vomiting in the first two hours following surgery was 
significantly higher than incidences in two to six hours or six to 24 in the 30% O2 control group 
(p = 0.003). Additionally, there are were no significant differences in incidence of nausea and 
vomiting between zero to two hours, two to six hours and six to 24 hours after surgery in the 
80% O2 intervention group. The authors conclude that 80% supplemental oxygen has a positive 
effect on PONV compared to 30% in children undergoing tonsillectomy especially in the first 
two hours postoperatively. The authors also admit that the results of this study conflict with a 
meta-analysis conducted by Orhan-Sungur et al. (2008), and other RCTs. The authors therefore 
suggest that there is need for further research regarding the effect of supplemental oxygen on 
PONV. Additionally, the authors suggest that beneficial effect of supplemental oxygen in on 
PONV in this study may be due to lowering serotonin levels in the pharynx. Because the results 
are not consistent with other findings, and because this intervention was conducted on a specific 
group of patients undergoing pediatric tonsillectomies, the results may not be valid or 
generalizable to larger populations. 
Supplemental Oxygen Does Not Prevent Postoperative Nausea and Vomiting after 
Gynecological Laparoscopy 
 McKeen, Arellano and O’Connell (2009) conducted a double blinded, randomized 
controlled trial with a level of evidence of II. The set out to test the hypothesis that high 
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intraoperative 80% oxygen compared to 30% oxygen reduces PONV in the first 24 hours 
following ambulatory gynecological laparoscopies under one hour in duration. This study was 
conducted in Halifax, Canada both in a Health Center and at patients’ homes following 
discharge. A power analysis was conducted and determined the need for 138 participants in each 
group. The researchers therefore enrolled 152 women into each group to allow for possible drop 
out. Through convenience sampling, a total of 145 women were included in the control group 
receiving standard 30% oxygen, and 147 women were included in the intervention group 
receiving 80% oxygen. In the control group six participants did not receive the intervention and 
data seven participants as not included for violations of protocol. In the intervention group two 
participants did not receive the intervention and data from five participants was not included for 
violations of protocol. Inclusion criteria for this study included being of ASA status I or II, and 
undergoing “ambulatory laparoscopic tubal ligation” (McKeen et al., 2009). Exclusion criteria 
for this study included having a BMI of 37 kg/m2 or more, anyone currently breastfeeding, 
having DM, requesting benzodiazepines preoperatively, having gastroparesis, using antiemetic 
for nausea and vomiting, using cannabis or opioids, having known substance abuse issues in the 
past six months, having a history of PONV that lasted over 24 hours or anyone requiring hospital 
admission postoperatively. After endotracheal intubation, participants received either 30% 
routine oxygen or 80% supplemental oxygen determined by computer randomization. The 
interventions were carried out by an anesthesiologist not blinded to the interventions while 
everyone else on the medical team and the patient were blinded to the intervention. Following 
anesthesia, all patients received O2 at two mL/min delivered via nasal cannula with supplemental 
oxygen given to maintain SpO2 above 92%. If patients experienced vomiting or nausea for than 
15 minutes or more, four to eight mg IV ondansetron was given as an antiemetic. If PONV was 
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still unresolved the patients received either IV dexamethasone and/or IV diphenhydrinate. An 
observer blinded to the interventions recorded episodes of nausea and vomiting every 30 minutes 
upon patient entry in PACU until time of discharge on a four-point scale from “none” to “severe” 
(McKeen et al., 2009). Additionally, at home patients recorded their episodes of vomiting and 
severity of nausea for the first 24 postoperative hours and reported them to observers via phone 
interviews. The primary outcome being analyzed was the incidence of PONV in the first 24 
hours and secondary outcomes being analyzed included doses of antiemetics taken 
postoperatively, postoperative time until admission of oral antiemetic, the amount of time it took 
to discharge the patient, and the PACU and at home scores regarding nausea and vomiting. 
Dichotomous variables were analyzed using Chi-squared tests, maximum nausea and vomiting 
scores were analyzed using the U test, and factors that could be potentially confounding were 
analyzed with t tests and Chi-squared tests. Results were presented as odds ratios (ORs) with 
95% CI, standard deviations, means, ratios and medians with statistical significance set at p < 
0.05. While the anesthesia duration was only longer for the supplemental oxygen intervention 
group, it was statistically significant (p = 0.02). The authors found that there were no statistically 
significant differences between the control and intervention group in early, late, pre-discharge, 
post-discharge or primary outcome PONV. Additionally, statistically significant predictors of 
PONV included previous history of PONV (p = 0.02), those of younger age (p = 0.005), surgery 
time (p = 0.04), in hospital morphine equivalents (p < 0.0001) and total morphine equivalents 24 
hours post-discharge (p = 0.002). The authors conclude that there is no clear benefit to using 
80% O2 compared to 30% O2 to reduce the incidence of PONV in patients undergoing 
laparoscopic gynecological surgery. Additionally, the authors assert that to better manage 
PONV, there need to be better methods of identifying the patients who are at risk for developing 
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PONV as well as better methods of decreasing postoperative opioid use. The results of this study 
are limited to a fairly specific population of patients undergoing laparoscopic tubal ligations and 
therefore may not be generalizable to the larger population. The results of this study also do not 
provide evidence for use of supplemental oxygen and therefore may not be clinically relevant for 
prevention of PONV.  
Effect of Intraoperative High Inspired Oxygen Fraction on Surgical Site Infection, 
Postoperative Nausea and Vomiting, and Pulmonary Function: Systematic Review and 
Meta-Analysis of Randomized Controlled Trials 
 Hovaguimian, Lysakowski, Elia, and Tramèr (2013) conducted a systematic review and 
meta-analysis with a level of evidence of I in order to determine the benefit of high inspired 
oxygen on surgical site infection (SSI) and PONV and determine the potential complications of 
high inspired oxygen on pulmonary function.  Multiple databases were searched for RCTs 
including MEDLINE, Central Databases and EmBase for terms including “oxygen,” 
“anesthesia,” “supplemental” and “and/or” for articles published up until the searchers were 
conducted in September of 2012 (Hovaguimian et al., 2013). Inclusion criteria included RCTs 
regarding adult patients undergoing surgery of any kind under general anesthesia, articles 
comparing high FIO2 of 80-100% to low or normal FIO2 of 30-40% and having patients that 
exhibited at least one of the three outcomes explored; PONV, SSI, or postoperative pulmonary 
outcomes. Articles were excluded if they were animal studies, were only abstracts, if high FIO2 
was delivered outside of the general anesthesia, if the patients had one-lung surgery, of if 
supplemental oxygen was delivered only postoperatively and not with the general anesthesia. 
One researcher reviewed articles for inclusion and exclusion criteria with a second researcher 
independently checking the first and a third resolving disputes or discrepancies between the other 
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two. A total of 22 RCTs were included in this review with 11 of them regarding PONV. One 
author alone extracted data from selected articles with a second author checking the data and a 
third resolving disputes or discrepancies between the other two. One author assessed articles for 
quality using an Oxford seven-point scale with four items including blinding, dropout, 
randomization and “concealment of treatment allocations” (Hovaguimian et al., 2013). RRs were 
calculated with 95% CIs for dichotomous data, mean differences with 95% CIs were calculated 
for continuous data, and all analyses were done using Microsoft Excel 12.2.3, STATA 11 and 
RevMan. The authors found that high FIO2 showed statistically significant benefit compared to 
normal FIO2 in prevention of late nausea (p < 0.05). Contrarily, there was no effect of statistical 
significance between high and low FIO2 on PONV. Also, the high FIO2 group had less incidence 
of nausea compared to low FIO2 and vomiting, though the results were not statistically 
significant. The authors conclude that the prophylactic antiemetic effect of high FIO2 is weak 
and that high FIO2 reduces PONV in patients without prophylactic antiemetic medication to a 
limited extent. The authors site several articles of conflicting results regarding the use of high 
inspired oxygen for PONV prevention. The authors admit that the study was slightly limited as it 
was only conducted on adults, and no prophylactic antiemetic medications were used causing the 
baseline risk for PONV were elevated and may have caused the high FIO2 to have more an effect 
than it would have had prophylactic antiemetic medication been used. This review brings to light 
the need for conclusive data regarding supplemental oxygen for PONV prevention and until 
more research is done, the results of this study cannot definitively conclude anything nor guide 
clinical practice nor patient care. 
Does Supplemental Oxygen Reduce Postoperative Nausea and Vomiting? A Meta-Analysis 
of Randomized Controlled Trials 
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Orhan-Sungur, Kranke, Sessler, and Apfel (2008) conducted a meta-analysis of RCTs 
with a level of evidence of I to “clarify” the effects of supplemental oxygen on prevention of 
PONV. Multiple databases were searched including MEDLINE, Cochrane Library, and Science 
Citation Index with search terms including “supplemental oxygen AND anesthesia,” and 
“[oxygen AND (nausea OR vomiting)]’ (Orhan-Sungur et al., 2008). The main outcomes were 
dichotomous data such as absence of presence of vomiting, nausea, or retching with FIO2 80% 
compared to FIO2 30-40%. Three of the authors each independently read and scored the abstracts 
and reports possibly meeting the inclusion criteria and assessed the articles for quality in areas 
such as randomization, blinding, allocation concealment, and description of withdrawals. Data 
was extracted for type of surgery, interventions, outcomes, risk factors, incidence of PONV in 
zero to six, six to 12 and zero to 24 hours following surgery and put into a Microsoft Excel 
document. RRs were calculated with a 95% CI comparing supplemental oxygen to room air, and 
when the CI did not include the number one, it was considered that there was a statistically 
significant difference between supplemental oxygen and room air. Five RCTs met the inclusion 
criteria and were included in the study with a total of 860 patients receiving supplemental 80% 
oxygen and 867 patients receiving standard 30-40% oxygen. The authors found that the RR for 
developing overall, early and late PONV within the first 24 hours following surgery in patients 
receiving 80% FIO2 compared to patients receiving 30-40% FIO2 were insignificant. It was also 
found that the data was similar between abdominal, non-abdominal, and all types of surgeries 
and any differences were statistically insignificant. Additionally, abdominal surgery patients 
experienced significantly less vomiting with high concentration of supplemental oxygen (p < 
0.05), however the data was insignificant with the exclusion of two initial studies. There were 
two studies that presented results of statistical significance indicating that high concentrations of 
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supplemental oxygen decrease PONV, however the results from these studies were not included 
in data analysis. The authors conclude that intraoperative supplemental oxygen at 80% FIO2 has 
no effect on PONV no matter the type of surgery and should not be recommended as a 
prophylactic treatment of PONV. While several studies have asserted the beneficial effects of 
high inspired oxygen on PONV, those results are not fully represented in this study and therefore 
all results on this topic must be interpreted with caution and should not yet inform clinical 
practice without further conclusive research.   
Supplemental Intravenous Fluid Therapy 
Effects of Intraoperative Liberal Fluid Therapy on Postoperative Nausea and Vomiting in 
Children – A Randomized Controlled Trial 
 Ashok, Bala, Bharti, Jain and Samujh (2017) state that not only is PONV unpleasant, 
emetic episodes can cause serious complications including suture dehiscence, aspiration, 
dehydration and imbalances of electrolytes. The authors conducted a double blind RCT with a 
level of evidence of II, in India, to determine the efficacy of liberal intraoperative fluid therapy 
with crystalloids on PONV in children. A power analysis was conducted and determined a need 
for 67 participants in both the restricted group receiving 10 mL/kg/hr and in the liberal group 
receiving 30 mL/kg/hr with an 𝛼 of 0.05. Convenience sampling was used to recruit 75 patients 
to each group, however two were lost to follow up in the liberal group, and three were lost in the 
restricted group yielding a total of 73 and 72 participants with analyzable results in each group 
respectively. Inclusion criteria including being ASA status I or II, being between the ages of 
three and seven, and being scheduled for elective penile or lower abdominal surgeries for less 
than one hour. Exclusion criteria included any renal or cardiovascular diseases, antiemetic use 
within 24 hours of surgery, having a history of PONV, having a BMI of 30 kg/m2 or more, 
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having a history of motion sickness, having a contraindication to caudal block, mental 
retardation, developmental delays or if the parents of the children could not be contacted over the 
phone. Each of the 150 children were randomized into the restricted or liberal therapy groups via 
computer generated randomization. All participants were required to fast for the same amount of 
time, underwent the same anesthesia and caudal blocks, and received either 10 mL/kg/hr or 30 
mL/kg/hr IV crystalloid fluid therapy intraoperatively of lactated ringers (LR) with only the 
anesthesiologist not being blinded to the intervention. A blinded investigator collected data 
regarding PONV in the PACU including episodes of retching, nausea, and vomiting with the 
patient receiving 0.1 mg/kg IV ondansetron upon the first episode and if symptoms still were 
unresolved after 30 minutes, 0.5 mg/kg IV promethazine was administered. The Face, Leg, 
Activity, Cry, Consolability (FLACC) scale from zero to 10 was used to assess postoperative 
pain and 15 mg/kg IV paracetamol was given if the FLACC score was four or greater. 
Additionally, 24 hours after discharge, the parents were interviewed over the phone to assess 
satisfaction regarding pain and antiemetic therapy on a scale of zero to 10 with zero being 
completely unsatisfied and 10 being completely satisfied. Quantitative variables were analyzed 
for normality, data was that normally distributed was analyzed with U tests, proportions were 
analyzed with t tests, and variables relating to time were compared with ANOVA. Statistical 
significance was set to be p < 0.05. The authors found that the number of incidences of PONV 
were significantly higher for the restricted group than the liberal group (p = 0.021). Also, the 
adjusted OR of PONV for the liberal group was 2.24 times higher than the restricted group (p = 
0.022). The patients in the restricted group consumed significantly more fluids postoperatively 
within the first six hours (p = 0.021) and the incidence of thirst in the restricted group was 
significantly higher than that of the liberal group (p <0.00001). Finally, parent satisfaction was 
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significantly higher in the liberal group than restricted group (p = 0.041). The authors conclude 
that PONV, thirst and parent satisfaction were all improved by the intervention of intraoperative 
administration of 30 mL/kg/hr LR solution compared to 10 mL/kg/hr LR solution. Though the 
study yielded definitive results, these results may not be generalizable to larger populations to 
patients undergoing more invasive or surgeries lasting longer than one hour.  
Preoperative Fluid Bolus and Reduction of Postoperative Nausea and Vomiting in Patients 
Undergoing Laparoscopic Gynecologic Surgery 
 Lambert, Wakim and Lambert (2009) site several studies that identify hypovolemia as 
one of the contributing factors to PONV incidence and because of this reason the authors 
conducted this study. This randomized controlled, clinical trial with a level of evidence of II was 
done to determine what effect a preoperative fluid bolus would have on PONV. This study was 
conducted in a large general hospital in Tennessee, United States. A power analysis was 
conducted and determined that in order yield results of statistical significant with p < 0.05, there 
was a need for 22 participants in the control group and 22 participants in the experimental group.  
Through convenience sampling, data was included for a total of 23 participants who received a 
fluid bolus in the experimental group and 23 participants who received the routine method of 
fluid replacement therapy after the removal of data from six participants due to noncompliance 
with study or anesthesia staff. The authors site inclusion criteria as being at least 18 years old, 
being ASA status I or II, having self-administered a Fleet’s enema, not being pregnant, being 
scheduled for non-emergency and ambulatory surgeries and having fasted since 12:00 midnight 
the night prior to surgery. Exclusion criteria included having congestive heart failure, a history of 
heart disease, DM, epilepsy, heart disease relating to the valves, mental disabilities, being a 
prisoner, having a history of PONV, or anyone taking antiemetics within 24 hours of surgery. 
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Participants were randomized into two groups however the method of randomization was not 
explicitly stated. Both participants and researchers were blinded to the interventions.  
Participants in the intervention group receiving a fluid bolus received up to 1000 mL of LR 
solution within an hour and the participants in the control group received the routine amount of 
LR solution as directed by the anesthesiologist. Both control and intervention groups received 
two mg IV midazolam preoperatively. All participants received general and routine methods of 
anesthesia. Upon admission to the PACU, patients were assessed for signs of nausea, vomiting or 
retching without verbal probing from the nurse who was blinded to the intervention. Data was 
also collected on the use of rescue antiemetics, baseline blood pressure (BP), BP after induction 
of supplemental fluids, and use of postoperative opioids. Data was analyzed with SPSS software 
for correlational, parametric and descriptive statistics with statistical significance set at p < 0.05. 
The authors found that there was a significantly correlation between incidence of nausea and 
vomiting and a decrease in systolic blood pressure in the group receiving routine fluid 
replacement therapy (p = 0.006). Also, the group receiving the fluid bolus experienced 
significantly fewer episodes of PONV than the control group (p = 0.0465). The authors conclude 
that preoperative intravenous fluid therapy is an effective way to reduce PONV and should be 
considered a routine therapy in management of PONV. The authors also note that there was a 
smaller decrease in systolic blood pressure in the group receiving routine fluid replacement 
therapy than the group receiving the bolus fluids and that bolus fluid therapy may not be an 
effective therapy for sustaining blood pressure postoperatively. Because this study included wide 
ranges of types of surgery, was conducted in a large hospital, was randomized and blinded with 
clear methods explained, this study is likely generalizable to larger populations and is clinically 
applicable. 
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Comparison of Dexamethasone or Intravenous Fluids or Combination of Both on 
Postoperative Nausea, Vomiting, and Pain in Pediatric Strabismus Surgery 
 Sayed, Riad and Ali (2016) state that up to 80% of pediatric patients receiving strabismus 
surgery experience PONV and because of this, they conducted this study. This randomized 
controlled trial with a level of evidence of II was conducted to compare the efficacy of 
dexamethasone antiemetic therapy combined with super hydration against either monotherapy 
for PONV in pediatric patients receiving strabismus surgery. The primary outcome for this study 
was the proportion of PONV in patients in each of the intervention groups and secondary 
outcomes included VAS scores, total analgesic medication consumption, the use of rescue 
antiemetics and adverse effects. This study was conducted in Asyut, Egypt. A power analysis 
was conducted to determine the number of participants necessary to yield results of statistical 
significance and determined the need for 38 participants in each group. A total of 40 patients 
were enrolled in each group to allow for possible drop out. Through convenience sampling, a 
total of 40 participants were included in each group of dexamethasone monotherapy, super 
hydration monotherapy, and combined dexamethasone with super hydration. The authors site 
inclusion criteria as having parental consent, being between the ages of six and 12 years of age, 
undergoing strabismus surgery, being of ASA status I or II, and undergoing general anesthesia. 
Exclusion criteria for this study included having a BMI in the 95th percentile or higher for sex 
and age, having DM, mental retardation, using psychoactive drugs or antiemetics within 24 hours 
of surgery or having a history of GERD. A computer generated random numbers which were 
then assigned to participants placing them in one of the three groups after IV access was 
established. The patients receiving dexamethasone monotherapy received 0.15 mg IV 
dexamethasone one minute before anesthesia induction and intraoperatively received 10 
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mL/kg/hr of LR solution. The patients receiving super hydration monotherapy intraoperatively 
received 30 mL/kg/hr of LR solution. The combination group received both 0.15 mg IV 
dexamethasone one minute before anesthesia induction and intraoperative LR solution of 30 
mL/kg/hr. All interventions were conducted in a double-blind fashion in which neither 
participant nor data collector knew the intervention. All participants had the same preoperative 
diet, same method of surgery performed by one of four physicians, same general method of 
anesthesia, same tracheal intubation, and received the same monitoring techniques. Directly 
following the extubation, each incident of retching and successful vomiting was recorded. 
Nausea was both observed by a blinded and trained nurse, and was self-reported by patient. 
PONV was assessed on a scale of zero to three with zero being “no nausea or vomiting” and 
three being “2 or more episodes of vomiting in 30 minutes” (Sayed et al., 2016). Any patient 
with a PONV score of three was said to have severe nausea and was given a rescue antiemetic of 
0.15 mg/kg IV ondansetron. Pain scores were assessed using a zero to ten VAS with zero being 
“no pain” and ten being “worst possible pain” (Sayed et al., 2016). Upon parental request or 
when VAS scores were three or higher, 0.15 mg/kg IV paracetamol was administered to control 
the pain.  All data regarding PONV was put into the timeframes of zero to two hours 
postoperatively, two to six hours postoperatively and six to 24 hours postoperatively. SPSS 
software was used to analyze the data which was later presented in the form of standard 
deviations, percentages, range, mean, and more. Variance was analyzed using the post hoc test, 
nonparametric data was assessed with the Kruskal-Wallis test, comparisons between groups were 
conducted via t tests, and Chi-squared tests were used to compare frequencies and percentages. 
The authors found that the incidence of PONV was significantly lower for combination therapy 
group than either monotherapy group (p < 0.001) and that the number of patients experiencing no 
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PONV was significantly higher in the combination therapy group than either monotherapy group 
(p < 0.01). The researchers also found that nausea alone was significantly lower in the 
combination therapy group than either monotherapy group (p < 0.03).  Additionally, rescue 
antiemetic therapy with ondansetron was significantly lower (p < 0.001) and dose used was 
significantly lower (p < 0.01) in the combination therapy group than either monotherapy group. 
In the end, there were no significant differences between either monotherapy group in incidence 
of PONV, number of participants experiencing no PONV, number of patients requiring rescue 
antiemetic use, dose of antiemetic used or VAS scores.  The authors conclude that the 
combination of prophylactic 0.15mg/kg dexamethasone with 30 mL/kg/hr LR is more effective 
than either monotherapy alone at reducing incidence and severity of PONV. Because the 
researchers adjusted the amount of fluid therapy to correlate with the amount of time spent 
fasting, the authors admit that there is potential bias in the form of potentially uncontrolled 
confounding variables, and in the differences in the amount of fluid therapy administered. 
Additionally, because this study focused specifically on pediatric strabismus surgery, the results 
may be difficult to generalize to larger populations. Though this study suffered from several 
limitations, it is still valid and likely relevant to several clinical settings. 
Effect of Intravenous Fluid Therapy on Postoperative Vomiting in Children Undergoing 
Tonsillectomy 
 Elgueta et al. (2013) assert that inexpensive prophylactic antiemetics used for POV are 
often not completely effective and can cause side effects and that an alternative equally cost 
effective preventative intervention could be supplemental fluid therapy. The authors conducted 
this randomized controlled trial in Santiago, Chile, with a level of evidence of II to determine the 
efficacy of super-hydration with LR solution for children undergoing tonsillectomies both with 
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and without adenoidectomies. A power analysis was conducted and determined the need for 42 
participants in each group of control and super-hydration to yield results with a power of 80% 
and 𝛼 of 0.05. To allow for possible drop out, 50 participants were recruited via convenience 
sampling and were enrolled in each of the treatment groups. The authors site inclusion criteria 
for this study as being between the ages of one and 12 years, being of ASA status I or II, those 
whose parents provided informed consent, and patients who were undergoing tonsillectomies 
and/or adenoidectomies under general anesthesia. Exclusion criteria for this study included 
having a BMI in the 95th percentile or greater, having a history of DM or mental retardation, 
having a known history of GERD, and those who took antiemetic or psychoactive medications 
within 24 hours of surgery. The 100 participants were randomized into one of two groups via a 
computer generated random numbers. All participants were required to fast for at least four hours 
prior to surgery, received the same method of anesthesia, were intubated via tracheal intubation, 
had their surgeries performed in the same way and were given intraoperative fluids. Only the rate 
of fluids administration was different from control to super-hydration group with the control 
receiving 10 mL/kg/hr LR solution and the super-hydration group receiving 30 mL/kg/hr LR 
solution in a double-blind fashion. The authors site the reason for only assessing vomiting and 
retching in data collection as the fact that nausea is very difficult to assess in children. Every 
episode of vomiting or retching following tracheal extubation and patient arrival in the PACU 
was recorded with the first incidence of retching, vomiting or both signifying the need for 0.15 
mg/kg IV ondansetron. If retching and vomiting continued after 20 minutes following the 
antiemetic administration of ondansetron, 0.015 mg/kg IV droperidol was administered. Pain was 
assessed with either a VAS of zero to ten with zero being “no pain” and ten being “worst 
possible pain” or a Children and Infants Postoperative Pain Scale (CHIPPS) of zero to ten 
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depending on the age and developmental level of the child being assessed (Elgueta et al., 2013). 
Pain scores were assessed every 15 minutes for the first hour and every 30 minutes for the 
second hour. Following discharge at the 24-hour postoperative mark, parents were interviewed 
via telephone to determine if there was any vomiting or retching at home. Normality of data was 
analyzed with Q-Q plots and the Shapiro-Wilk test. Between group comparisons were analyzed 
with t tests, the Shapiro-Wilk test, or Wilcoxon rank-sum test. Fisher’s tests and Chi-squared 
tests were used to interpret proportions and all data was considered to be statistically significant 
with p < 0.05 considered the cut off for statistical significance. The authors found that 
participants receiving 10m L/kg/hr of LR were significantly more likely to experience vomiting 
or retching than the participants who received intraoperative super-hydration with LR solution (p 
= 0.0026). Despite the relative efficacy at preventing POV compared to hydration with 10 
mL/kg/hr LR solution, the authors believe that intraoperative super-hydration alone is not a 
sufficient prophylactic intervention for POV. The authors conclude that intraoperative super-
hydration with 30 mL/kg/hr LR solution is an economic alternative prophylactic intervention to 
pharmacology in decreasing the risk of POV. This study was conducted on a small and specific 
population, and because of this it may be difficult to generalize to other populations, however, 
this study is clinically significant in preventing PONV in children.  
Supplemental Intravenous Crystalloids for the Prevention of Postoperative Nausea and 
Vomiting: Quantitative Review 
 Apfel et al. (2012) published a meta-analysis of all relevant RCTs with a level of 
evidence of I in The British Journal of Anesthesia. A total of seven authors conducted this study 
to determine if supplemental IV hydration with crystalloids decreases PON, POV, PONV or use 
of rescue antiemetics as compared to more traditional fluid therapy. The authors conducted 
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searches on EmBase, the Cochrane Library, PubMed and Web of Science including terms such 
as “preoperative,” “hydration,” “crystalloid,” “intraoperative,” “PONV,” and “postanesthesia.” 
(Apfel et al., 2012). Inclusion criteria for this study included being an adult or adolescent patient 
at least 16 years old undergoing surgical procedures, and IV hydration with crystalloid solutions. 
Two authors each reviewed the abstracts and full reports that may have met the inclusion criteria. 
The same two authors extracted data that was dichotomous in nature such as incidence of PON, 
incidence of POV, incidence of PONV, use of rescue antiemetics and incidence of side effects 
from medications. A third author would resolve any discrepancies in data collection and when 
data from tables was unclear, it was extrapolated via graphs. A total of 15 RCTs were included in 
the review with a total of 1,570 patients with 787 of them receiving supplemental crystalloid 
fluid therapy and 783 of them receiving conservative fluid therapy. In this study, the 
conservative regimen consisted of zero to two mL/kg and the supplemental fluid regime 
consisted of 15-30 mL/kg. A Cochrane scale for risk for risk of bias was used to analyses the 15 
RCTs for quality out of which several showed moderate risk for bias. Meta-analyses were 
conducted on the data collected with Review Manager 5.1 to determine RRs with CIs of 95% 
and statistical significance set at p < 0.05. The authors found that supplemental crystalloids 
significantly reduced early PON (p = 0.003), late PON (p = 0.004) and PON overall (p = 0.02) 
compared to the conservative fluid regimen. Additionally, supplemental crystalloids significantly 
reduced overall POV (p = 0.004) compared to the conservative fluid regimen. Supplemental 
crystalloids significantly reduced late PONV (p < 0.001) and overall PONV (p = 0.003). The 
authors also found that supplemental crystalloids reduced the need for rescue antiemetic 
medication significantly (p < 0.001) compared to the conservative fluid regimen. These findings 
are consistent with other findings regarding supplemental IV in the treatment and prevention of 
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PONV. The authors conclude that the use of supplemental IV crystalloids reduces PONV, 
reduces the need for rescue antiemetic medication, and can be used as a prophylactic antiemetic 
intervention. While the results of this study are doubtlessly clinically significant and are 
generalizable to larger populations, this review suffered from several limitations. The authors 
admit that many of the samples included in the review had treatment sizes of 50 or less which 
may be why some of the results did not reach statistical significance. Additionally, both 
preoperative and intraoperative fluid therapies were included which may have influenced the 
results. Finally, there was a very wide range of fluids administered between studies from two to 
30 mL/kg/hr and future studies may be needed to further narrow down the results. 
Serotonin 5HT3 Antagonists 
5HT3 Antagonists for Prophylaxis of Postoperative Nausea and Vomiting in Breast 
Surgery: A Meta-Analysis 
Singhal, Kannan and Gota (2012) conducted a systematic review and meta-analysis with 
a level of evidence I originally published in the Journal of Postgraduate Medicine. This review 
set out to determine the efficacy of 5HT3 antagonists compared to non-5HT3 antagonists for 
prevention of PONV in women undergoing breast surgeries. The databases searched included the 
Cochrane Central Register of Controlled Trials and PubMed for terms including “PONV,” 
“prevention,” “antiemetic,” “mastectomy,” and “breast surgery” (Singhal et al., 2012). Two of 
the three researchers conducted the search and analyzed the articles, titles, abstracts and 
correspondences for compliance with inclusion criteria including being published in English, 
RCTs, having patients that were undergoing breast surgeries, comparison one or more 5HT3 
antagonist with other types of antiemetics or placebo, patients who were undergoing general 
anesthesia, and antiemetic administration prophylactically as opposed to as a treatment. 
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Exclusion criteria for this review included trials that evaluated anesthesia other than general 
anesthesia or used interventions for PONV that were non-pharmacologic. All included articles 
were assessed for quality using the Jadad scale and scored > 3 therefore determining their quality 
as good. Publication bias was assessed using funnel plots. A total of 19 RCTs were included in 
the review with a total of 2,053 participants. In the RCTs analyzed, the control consisted of 
either placebo or active controls and the intervention consisted of 5HT3 agonists. Within this 
study. the primary outcome included incidence of PONV and secondary outcomes included use 
of rescue antiemetics for PONV, incidence of nausea and incidence of vomiting. Analysis of 
subgroup data included duration of surgery, duration of anesthesia, and timing of prophylactic 
antiemetic administration. Two of the reviewers each independently extracted data from the 
RCTs including demographic data and primary and secondary outcomes. Data was analyzed via 
RevMan software with ORs with CI of 95%. The authors found that compared to placebo and 
active controls, 5HT3 antagonists were more effective in preventing PONV, and compared to 
placebo were also more effective at preventing PON, POV and in decreasing the need for rescue 
antiemetics. On the other hand, compared to active controls, 5HT3 antagonists did not 
significantly reduce the need for rescue antiemetics. Compared to placebo, the incidence of 
PONV was significantly reduced for ondansetron (p = 0.0001), granisetron (p < 0.00001) and for 
other 5HT3 antagonists (p < 0.00001). The OR of PONV was reduced by 82% for 5HT3 
antagonists compared to placebo (p < 0.0001). Compared to placebos, 5HT3 antagonists did not 
produce significantly more incidences of adverse effects. 5HT3 antagonists compared to active 
controls significantly better prevented PONV (P = 0.01) but did not have a significant effect on 
need for recue antiemetics. Granisetron either combined with dexamethasone or droperidol was 
more effective in combating PONV (p = 0.002). The authors conclude that 5HT3 antagonists are 
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effective at reducing PON, POV, and reducing the need for rescue antiemetics with granisetron 
and ondansetron being most effective at preventing POV. Additionally, the authors conclude that 
5HT3 antagonists should be considered primary prophylactic agents to prevent PONV in women 
undergoing breast surgery. The authors admit that their findings are not consistent with the 
findings of a Cochrane review regarding specific drugs and their efficacy, however both studies 
indicate that 5HT3 antagonists are effective for PONV prevention and treatment. The authors 
admit that all but one study used the recommended optimal dose of 4mg ondansetron which may 
have influenced results very slightly. Despite this small limitation, this study produced high 
quality evidence that is generalizable to larger populations and is clinically relevant for 
improving patient care and patient outcomes. 
Comparative Safety of Serotonin (5HT3) Receptor Antagonists in Patients Undergoing 
Surgery: A Systematic Review and Meta-Analysis 
 Tricco et al. (2015) produced a systematic review and meta-analysis with a level of 
evidence of I under BMC Medicine to determine the safeties of different 5HT3 antagonists. A 
total of 21 authors produced the review. An experienced librarian searched for articles in 
MEDLINE, the Cochrane Central Register of Controlled Trials and EmBase though the authors 
to not explicitly state which terms were searched for within these databases.  Eligibility criteria 
for this review including being a CCT, RCT, quasi-experimental RCT, quasi-experimental study, 
or cohort study originally published in English involving patients who received 5HT3 antagonists 
for PON, POV, or PONV and underwent surgery of any kind. The primary outcome being 
explored was the incidence of arrhythmias with secondary outcomes being mortality, delirium, 
PR elongation and QT elongation. Pairs of reviewers independently screened potential articles 
for compliance with inclusion criteria, to abstract data, and to analyze the quality of evidence of 
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the selected articles with discrepancies being resolved via discussions. A total of 120 studies of 
various designs were included in analysis with a total of 27,787 participants with 97% of the 
studies being RCTs. To assess for quality and bias, quasi-experimental studies were assessed 
using the “Cochrane Effective Practice and Organization of Care risk for bias tool,” and cohort 
studies were assessed using the “Newcastle-Ottawa Scale,” and all studies that reported harm 
were assessed using the “McMaster Quality Assessment Scale of Harms” (Tricco et al., 2015). 
The authors found that compared to patients receiving placebo, dolasetron, granisetron, 
ondansetron and ondansetron combined with dexamethasone, the patients receiving granisetron 
combined with dexamethasone experienced significantly higher numbers of arrhythmias. 
Additionally, in terms of arrhythmias, dolasetron and ondansetron in combination with 
dexamethasone are safest overall, and ondansetron in combination with dexamethasone is safest 
for children if administered intraoperatively. No significant differences in delirium or mortality 
existed between different 5HT3 antagonists. The authors conclude that granisetron plus 
dexamethasone may increase the risk for cardiac arrhythmias. The authors do not state if the 
results are consistent with other studies potentially because this was one of the first studies in this 
area, however they do state that the results “were consistent across subgroup and sensitivity 
analysis” (Tricco et al., 2015). The authors also admit there were several limitations to their 
review including the fact that follow up time period varied greatly from under six hours to 
greater than a week. Additionally, one of the authors owns stock in a company that produces 
medication used in one intervention. Even more, not all results in this study were RCT, and the 
quasi-experimental studies often had high risk for bias. Despite these limitations, the rigor of this 
study is good, and the study is very important clinically. The results can and should be applied to 
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larger populations to improve patient outcomes and prevent the adverse effects of arrhythmias in 
patients receiving granisetron with dexamethasone.  
Comparison of the Efficacy of Ondansetron and Granisetron to Prevent Postoperative 
Nausea and Vomiting After Laparoscopic Cholecystectomy: A Systematic Review and 
Meta-Analysis 
 Wu et al. (2013) conducted a systematic review and meta-analysis of RCTs with a level 
of evidence of I in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques order to 
determine the efficacy of ondansetron and granisetron on PONV in patients undergoing 
laparoscopic cholecystectomies. A total of four authors conducted the review. Databases 
searched included MEDLINE, the Science Citation Index Expanded, Cochrane Register of 
Controlled Trials, EmBase, PubMed, Google Scholar, Chinese Biomedical Database, and China 
National Knowledge Infrastructure Whole Article Database. Search terms included “laparoscopic 
cholecystectomy,” “Zofran,” “ondansetron,” and “granisetron” (Wu et al., 2013). The primary 
author reviewed article titles and abstracts to exclude articles based on relevance to the review, 
two authors reviewed titles, abstracts, and keywords for relevance and then obtained the full texts 
of the articles with discrepancies being resolved via discussion. Inclusion criteria for this review 
included RCTs, patients who underwent laparoscopic cholecystectomies exclusively, received 
interventions of prophylactic IV ondansetron and/or prophylactic IV granisetron in comparison 
with each other and measured the incidence of early PONV and total PONV. Two of the four 
authors assessed all studies for methodological quality for areas including blinding, 
randomization, selective reporting, sources of funding, differences in baselines, study design and 
allocation concealment. A total of five RCTs with a total of 244 participants were included in the 
systematic review and meta-analysis. The authors found that the incidence is PONV in the early 
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postoperative period were higher for those receiving ondansetron than those receiving 
granisetron though the differences were not statistically significant. Additionally, PONV total 
incidence was higher for those receiving ondansetron than those receiving granisetron though the 
differences were not statistically significant. The need for rescue antiemetics was higher for 
those receiving ondansetron than those receiving granisetron though the differences were not 
statistically significant. Finally, the number of patients with headaches was fewer in the 
ondansetron groups than the granisetron groups though the difference was not statistically 
significant. The authors conclude that ondansetron and granisetron are equally effective at 
preventing PONV. Despite these results, the review suffered from several limitations. Two of the 
five studies presented unclear risk for bias while 3 presented high risk for bias. The authors also 
mention that there may be a relationship between dose and effect of medication; one study 
adopted doses that may have caused it to appear that ondansetron has better therapeutic effects. 
The authors mention that there is further need for research on dose and effect of both 
ondansetron and granisetron. Due to the evidence of publication bias within this review and for 
the results mentioned above, the results should be interpreted with caution. 
Dexamethasone, Ondansetron, and their Combination and Postoperative Nausea and 
Vomiting in Children Undergoing Strabismus Surgery: A Meta-Analysis of Randomized 
Controlled Trials 
 Shen et al. (2014) published a systematic review and meta-analysis of RCTs with a level 
of evidence of I in Pediatric Anesthesia to determine the safety and efficacy of ondansetron and 
dexamethasone on PONV in pediatric patients receiving surgery for strabismus. A total of five 
authors published the review. The primary outcome being explored was incidence of PONV 
within 24 hours of surgery and secondary outcomes included the need for rescue antiemetics and 
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complications. Databases searched included MEDLINE, PubMed, EmBase, Cochrane databases 
and SCOPUS for terms including “strabismus,” “postoperative,” “PONV,” “nausea,” 
“vomiting,” “dexamethasone,” “glucocorticoid,” “steroid,” “antiserotonin,” and “ondansetron” in 
articles published up to November of 2013 (Shen et al., 2014). Inclusion criteria for studies 
included being a RCT comparing ondansetron or dexamethasone and placebo in pediatric 
strabismus surgery patients, clearly listing all protocols and drugs used and clearly defining 
vomiting and nausea. Exclusion criteria for this review included studies in which participants 
were receiving surgeries other than strabismus surgeries, if ondansetron or dexamethasone were 
administered via any route other than intravenously, if outcomes were not clearly reported, or if 
there was any overlap between cohorts, authors or centers in which the interventions were 
conducted. A total of 13 RCTs were selected for analysis with a total of 2,006 patients with the 
control being treated as an active control or placebo and the intervention consisting of 5HT3 
antagonists. Two of the five authors independently extracted data and a third author resolved any 
discrepancies regarding the data collection between the other two authors. Two of the five 
authors reviewed each article and assessed them for quality in regard to allocation concealment, 
blinding, randomization, dropouts and other biases with a third author resolving any 
discrepancies in these analyses. All articles were found to be of good methodological quality and 
had strong evidence. Statistical analysis was conducted according to the Cochrane Collaboration 
recommendations as well as the guidelines of Quality of Reporting of Meta-Analyses PRISMA. 
The authors found that compared to placebo, incidences of POV with prophylactic 
dexamethasone were significantly reduced (p = 0.0002). Doses of dexamethasone compared to 
placebo 0.25mg/kg, 0.5 mg/kg and 1 mg/kg in relation to incidence of POV were not 
significantly different. Also, compared to placebo, incidences of PONV with prophylactic 
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ondansetron were significantly lower (p < 0.0005) and significantly reduced the need for rescue 
antiemetics (p < 0.00001). Dexamethasone combined with ondansetron compared to ondansetron 
alone significantly reduced incidence of POV (p = 0.0002). The authors conclude that the overall 
incidence of PONV in comparison between dexamethasone and ondansetron was not 
significantly different nor was the need for rescue antiemetic medication. Finally, prophylactic 
ondansetron or dexamethasone improves PONV in pediatric strabismus surgery. Ondansetron 
reduces the need for rescue antiemetic medication, and a combination of ondansetron and 
dexamethasone should be administered prophylactically to reduce overall PONV. Shen et al. 
(2014) state that their review is consistent with others. Due to the strong quality of evidence, 
these results are clinically applicable though they may not be generalizable to larger populations.  
Dexamethasone Combined with Other Antiemetics Versus Single Antiemetics for 
Prevention of Postoperative Nausea and Vomiting after Laparoscopic Cholecystectomy: An 
Updated Systematic Review and Meta-Analysis 
 Awad et al., (2016) updated a systematic review and meta-analysis with a level of 
evidence of I in the International Journal of Surgery in order to determine both the safety and 
efficacy of dexamethasone combined with other antiemetics compared to monotherapy 
antiemetics in preventing PONV in laparoscopic cholecystectomy patients. A total of seven 
authors published the review. The authors searched for articles published up to August of 2016 in 
databases including SCOPUS, PubMed, EmBase, and Web of Science using the keywords of 
“dexamethasone AND cholecystectomy” (Awad et al., 2016). Four authors screened the titles 
and abstracts for relevance and then screened the full text for compliance with inclusion and 
exclusion criteria. Inclusion criteria for this review included being a RCT, comparing single 
antiemetics with dexamethasone in combination with another antiemetic, reporting of incidence 
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of PONV as dichotomous and involving patients who received laparoscopic cholecystectomies. 
Exclusion criteria for this review included studies that were observational, non-randomized, 
reviews, theses, were chapters of books, studies that were not available in full text format, 
studies that were not available in English, studies that had unreliable data, and studies that had 
been retracted due to false data. A total of 14 RCTs were included in this review with a total of 
1542 participants; 816 participants in the combination antiemetic groups and 726 patients in the 
single antiemetic groups. Two of the seven authors extracted data independently. Data was 
classified into three periods of PONV including early PONV of zero to two hours, zero to four 
hours or zero to six hours, late PONV of more than six hours and overall PONV of zero to 24 
hours. Two of the seven authors analyzed all articles for quality using “The Cochrane 
Collaboration risk of bias tool” and found that all articles were of moderate to high quality 
(Awad et al., 2016). The authors found that dexamethasone in combination with additional 
antiemetics compared to single antiemetics was significantly more beneficial for reducing early 
PONV (p < 0.0001), late PONV (p < 0.0001) and overall PONV (p < 0.0001) and also decreased 
need for a rescue antiemetic (p < 0.0001). Single antiemetic and combination of dexamethasone 
and additional antiemetic medication did not show significant differences in incidence of adverse 
effects including sedation, urinary retention, headache, itching or dizziness suggesting that 
combination with dexamethasone is no more dangerous than single antiemetic medication for 
PONV prevention. Dexamethasone in combination with ondansetron compared to ondansetron 
alone was significantly more beneficial for reducing early PONV (p = 0.005), late PONV (p = 
0.008) and overall PONV (p = 0.02) as well as decreased need for a rescue antiemetic (p = 0.03). 
Dexamethasone with metoclopramide compared to metoclopramide alone was significantly more 
beneficial for reducing early PONV (p = 0.0004), late PONV (p = 0.0002) and overall PONV (p 
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< 0.0001). Dexamethasone in combination with ramosetron compared to ramosetron alone was 
not statistically more beneficial for reducing early, late or overall PONV but significantly 
decreased need for a rescue antiemetic (p = 0.01). Dexamethasone in combination with 
dolasetron compared to dolasetron alone was significantly more beneficial for reducing overall 
PONV (p < 0.0002). Dexamethasone in combination with ondansetron compared to 
dexamethasone alone was significantly more beneficial for reducing overall PONV (p = 0.02) as 
well as decreased need for a rescue antiemetic (p = 0.03). Dexamethasone combined with 
granisetron compared to granisetron alone was significantly more beneficial for reducing overall 
PONV (p = 0.03). Dexamethasone combined with palonosetron compared to palonosetron alone 
was significantly more beneficial for reducing early PONV (p = 0.002) and overall PONV (p < 
0.0001) as well as decreased need for a rescue antiemetic (p = 0.005). The authors conclude that 
dexamethasone in combination with other antiemetics is more beneficial for preventing PONV 
and reduces the need for other rescue antiemetics except for combination of dexamethasone with 
ramosetron which was not as beneficial in any postoperative period and dexamethasone with 
granisetron which was not as beneficial in the early postoperative period. One limitation of this 
was that for the studies that did not report data on overall PONV from zero to 24 hours, the 
researchers used data from the highest number of incidences in the longest timeframe specified 
in the study which may have influenced the results regarding the overall PONV period. 
Similarly, depending on the study, early PONV was defined as zero to two hours, zero to four 
hours or zero to six hours and PONV could be different in the first two hours than the first six 
which may have also affected the results regarding early PONV. The data provided on 
dolasetron, granisetron and palonosetron came from single studies and therefore more research is 
needed to definitively comment on their effect when combined with dexamethasone compared to 
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their single use in prevention of PONV. Despite these limitations, this study is of a high level of 
evidence including only studies of moderate to high quality and yielded strong results. For these 
reasons. the study is clinically applicable and should be used to better patients’ outcomes and 
care.  
Conclusion 
 The articles reviewed in this chapter addressed several of the integrative therapies 
available to prevent and treat PONV including aromatherapy, P6 acupuncture, supplemental 
oxygen, supplemental IV fluid therapy and 5HT3 pharmacotherapy. The 27 articles reviewed 
included quasi-experimental studies, RCTs, systematic reviews and meta-analyses ranging from 
a level of evidence of I to III. The literature revealed that PONV is a complex issue with many 
facets and that not one approach of managing PONV is perfect. The cost-benefit analysis for 
treatments and interventions in healthcare are often very important. The literature reviewed 
provided sound evidence for cost-effective treatments such as deep breathing (N = 2), 
aromatherapy with IPA, ginger or peppermint oil (N = 5), P6 wrist acupuncture (N = 5) and 
supplemental IV fluid therapy (N = 4). Overall, the results of the literature reviewed indicate a 
variety of effective treatment options for patients experiencing PONV ranging from minimally 
invasive all the way to pharmacotherapy. The variety of effective interventions allow for both 
healthcare professionals and patients the freedom of choice in treatment. Additionally, the 
variety of treatment options allow for nursing staff to utilize the principles of integrative nursing 
starting with the least invasive and intensive treatment possible and working their way up.  
 Future research exploring which scents of essential oils are beneficial in aromatherapy to 
manage PONV would be very beneficial. The results yielded from the studies regarding 
aromatherapy were varied, likely due to the personal preferences and sensitivities to scent. 
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Additionally, it is unclear as to whether the beneficial effects of aromatherapy are from the 
inhalant or from the nature of deep breathing itself that accompanied the majority of 
aromatherapy interventions explored in this thesis (Cronin et al., 2015). Furthermore, additional 
research exploring intraoperative fluid therapy versus preoperative fluid therapy would better 
guide clinicians in their use of supplemental IV fluid therapy to prevent PONV. Based on this 
review of literature, the evidence-based best practice recommendations in place for treating and 
managing PONV need to be updated to include more of the alternative therapies to allow for 
better patient care and additional opportunities for nursing staff to successfully employ the 
principles of integrative nursing. 
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CHAPTER 3 
Best Practice Recommendations: Prevention and Treatment of PONV 
The purpose of this thesis was to create best practice recommendations to both treat and 
prevent PONV with an integrative nursing approach moving from interventions of least invasive 
to most in order to reduce the post-surgical complications, healthcare costs and labor associated 
with increased PONV. The proposed best practice recommendations in Table 1 will help nursing 
and healthcare staff to reduce the episodes of PONV and better tailor their approaches to treating 
and managing PONV to each patient.  
The literature reviewed in Chapter 2 provided valuable information on some of the most 
common interventions used in the PACU for management of PONV as well as some both 
promising and emerging interventions used for PONV. As the considerable amounts of research 
show, the nursing interventions used to manage PONV do not fully alleviate the unpleasant and 
potentially dangerous condition that 20% to 30% of all postoperative patients face (Cutshall & 
Van Getson, 2014). Because PONV is a multifaceted healthcare issue, it requires a multifaceted 
approach to management as well. The review of literature details the beneficial effect of using 
acupuncture on the P6 acupoint site, liberal supplemental fluid therapy with crystalloid solutions 
and the use of ondansetron in combination with dexamethasone for treating and preventing 
PONV. While the effects of aromatherapy and supplemental oxygen on PONV are also explored 
in this thesis, the results have a weak beneficial effect and are not considered strong evidence. 
Because the research on aromatherapy and supplemental oxygen is weak, the best practice 
recommendations for both modalities must be interpreted with caution and if used, used 
sparingly and appropriately. 
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The levels of evidence in the following tables is derived from a rating system for the 
hierarchy of evidence (Guayatt & Rennie, 2002). Based on this rating system, level I evidence 
includes meta-analysis or systematic reviews of  all RCTs that may be relevant. Level II 
evidence includes RCTs that are of rigorous design. Level of evidence of III includes controlled 
trials that lack randomization but are well-designed. Data that was from case-control, cohort, 
qualitative, or descriptive studies were determined of a level of evidence greater than III and 
therefore not strong evidence and were not further analyzed in this honors thesis (Guayatt & 
Rennie, 2002).  
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Table 1 
Best Practice Recommendation for Use of Aromatherapy for Prevention and Treatment of PONV 
Recommendation Rationale References Level of 
Evidence 
 
 
 
 
 
 
 
Use of Inhaled 
Ginger Essential 
Oil 
 
 
Ginger has 
powerful antiemetic 
properties, can 
reduce 
gastrointestinal 
distress and is an 
effective antiemetic 
that can be used for 
PONV including 
patients undergoing 
abdominal 
surgeries. 
 
 
Adib-Hajbaghery, M., Hosseini, F. S. 
(2015). Investigating the effects of inhaling 
ginger essence of post-nephrectomy nausea 
and vomiting. Complementary Therapies 
in Medicine, 23(6), 827-831. doi: 
10.1016/j.ctim.2015.10.002 
 
 
 
 
Level II 
 
Lee, Y. R., & Shin, H. S. (2017). 
Effectiveness of ginger essential oil on 
postoperative nausea and vomiting in 
abdominal surgery patients. The Journal of 
Alternative and Complementary Medicine, 
23(3), 196-200. doi: 
10.1089/acm.2015.0328 
 
 
 
 
 
Level III 
 
 
 
 
 
 
Use of Inhaled 
Peppermint Oil 
 
 
 
Peppermint oil can 
reduce intensity of 
nausea and 
increases in 
effectivity for 
controlled PONV 
when used in 
conjunction with 
controlled 
breathing. 
 
Briggs, P., Hawrylack, H., & Mooney, R. 
(2016). Inhaled peppermint oil for postop 
nausea in patients undergoing cardiac 
surgery. Nursing2016, 46(7), 61-67. doi: 
10.1097/01.NURSE.0000482882.38607.5c 
 
 
 
 
Level III 
 
Sites, D. S., Johnson, N. T., Miller, J. A., 
Torbush, P. H., Hardin, J. S., Knowles, S. 
S., … Tart, R. C. (2014). Controlled 
breathing with or without peppermint 
aromatherapy for postoperative nausea 
and/or vomiting symptom relief: a 
randomized controlled trial. Journal of 
PeriAnesthesia Nursing, 29(1), 12-19. doi: 
10.1016/j.jopan.2013.09.008 
 
 
 
 
 
 
Level II 
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Implementation 
of Controlled 
Breathing 
Exercises 
 
 
 
 
 
Controlled 
breathing both with 
and without inhaled 
aromatherapies of 
peppermint oil and 
isopropyl alcohol 
may decrease 
PONV. 
 
Cronin, S. N., Odom-Forren, J., Roberts, 
H., Thomas, M., Williams, S., & Wright, 
M. I. (2015). Effects of controlled 
breathing, with or without aromatherapy, 
in the treatment of postoperative nausea. 
Journal of PeriAnesthesia Nursing, 30(5), 
389-397. doi: 10.1016/j.jopan.2015.03.010 
 
 
 
 
 
Level III 
 
Sites, D. S., Johnson, N. T., Miller, J. A., 
Torbush, P. H., Hardin, J. S., Knowles, S. 
S., … Tart, R. C. (2014). Controlled 
breathing with or without peppermint 
aromatherapy for postoperative nausea 
and/or vomiting symptom relief: a 
randomized controlled trial. Journal of 
PeriAnesthesia Nursing, 29(1), 12-19. doi: 
10.1016/j.jopan.2013.09.008 
 
 
 
 
 
 
Level II 
 
 
 
 
Use of Inhaled 
Isopropyl 
Alcohol 
 
Inhaled isopropyl 
alcohol is as 
effective as 
promethazine for 
treatment of PONV, 
is more cost 
effective, is easier 
to administer and 
works faster. 
 
 
Pellegrini, J., DeLoge, J,. Bennet, J., & 
Kelly, J. (2009). Comparison of inhalation 
of isopropyl alcohol vs promethazine in 
treatment of postoperative nausea and 
vomiting (PONV) in patients identified as 
at high risk for developing PONV. AANA 
Journal, 77(4), 293-299. 
 
 
 
 
 
Level II 
 
While there are potential positive benefits of inhaled essential oils and controlled 
breathing with ginger essential oil, peppermint oil and isopropyl alcohol, these results should be 
interpreted with caution and the benefit of intervention may in fact come from deep breathing. 
Hines et al. (2018) assert in a systematic review with level of evidence of I that the data 
regarding aromatherapy as treatment for PONV is of low quality and may reduce use of rescue 
antiemetics and have effectivities similar to those of placebos and much more research is needed 
to determine the true efficacy of inhaled aromatherapy for treatment of PONV. 
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Table 2 
Best Practice Recommendation Using P6 Acupoint Acupuncture for Prevention and Treatment of 
PONV 
Recommendation Rationale References Level of 
Evidence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Implementation 
of Intraoperative 
P6 Acupoint 
Acupuncture 
 
Intraoperative P6 
acupuncture is 
effective at 
reducing PONV for 
both adult and 
pediatric patients. 
Intraoperative P6 
acupuncture may 
be as effective or 
more effective at 
reducing PONV 
than 
metoclopramide, 
metoclopramide 
with 
dexamethasone and 
other traditional 
pharmacotherapies. 
Additionally, 
intraoperative P6 
acupuncture has 
less side effects and 
is more cost 
effective than 
traditional 
pharmacotherapy 
used to manage 
PONV. 
 
 
Albooghobeish, M., Mohtadi, A., Saidkhani, 
V., Fallah, H., Behaein, K., Nesionpour, S., & 
Nikbakht, R. (2017). Comparison between 
effects of acupuncture and metoclopramide on 
postoperative nausea and vomiting after 
gynaecological laparoscopy: a randomized 
controlled trial. Anesthesiology and Pain 
Medicine, 7(5). doi: 10.5812/aapm.12876 
 
 
 
 
 
 
Level II 
 
Bakhshaei, M. H., Khoshraftar, E., Shoja, S., 
& Mehrabi S. (2018). Comparison of wrist 
acupuncture point P6 with pharmacologic 
management to prevent postoperative nausea 
and vomiting in patients undergoing 
laparotomy: a double blind study. World 
Family Medicine, 16(2), 73-76. doi: 
10.5742/MEWFM.2018.93242 
 
 
 
 
 
Level II 
 
Shin, H. C., Kim, J. S., Lee, S. K., Kwon, S. 
H., Kim, M. S., Lee, E. J., & Yoon, Y. J. 
(2016). The effect of acupuncture on 
postoperative nausea and vomiting after 
pediatric tonsillectomy: A meta-analysis and 
systematic review. The Laryngoscope, 126(8), 
1761-1767. doi: 
http://dx.doi.org.ezproxy4.library.arizona.edu/ 
10.1002/lary.25883 
 
 
 
 
 
 
Level I 
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Implementation 
of P6 Acupoint 
Acupuncture 
 
Acupuncture of 
acupoint P6 greatly 
reduces the need 
for rescue 
antiemetics, 
incidences of 
PONV and is as 
effective as 
traditional 
antiemetic 
pharmacotherapies 
for treating PONV. 
 
 
Lee, A., Chan, S., & Fan, L. (2015). 
Stimulation of the wrist acupuncture point 
PC6 for preventing postoperative nausea and 
vomiting (review). Cochrane Database of 
Systematic Reviews, 11. doi: 
10.1002/14651858.CD003281.pub4 
 
 
 
 
Level I 
 
 
 
Implementation 
of Acupuncture 
of Acupoint P6 
in Conjunction 
with Other 
Acupoints 
 
The effectivity of 
acupuncture at 
acupoint P6 for 
reducing incidence 
of PONV increases 
significantly when 
combined with 
additional 
acupoints. 
 
 
Cheong, K. B., Zhang, J., Huang, Y., & Zhang, 
Z. (2013). The effectiveness of acupuncture in 
prevention and treatment of postoperative 
nausea and vomiting – a systematic review 
and meta-analysis. PLoS One, 8(12). doi: 
10.137/journal.pone.0082474 
 
 
 
 
 
Level I 
 
 All research reviewed regarding acupuncture using the P6 acupoint site overwhelmingly 
indicate that it is effective at managing PONV when used intraoperatively, postoperatively, 
unilaterally, bilaterally, in conjunction with pharmacologic antiemetics and when used alone. Lee 
et al. (2015) assert that stimulation of the P6 acupoint both through acupressure and acupuncture 
is comparable to antiemetics. Though this thesis does not focus on the benefits of acupressure of 
the P6 acupoint, it is beneficial and can be used in conjunction with acupuncture of the P6 
acupoint as demonstrated by Lee et al. (2015). Additionally, as demonstrated in the systematic 
review and meta-analysis conducted by Cheong et al. (2013), acupuncture of P6 acupoints in 
conjunction with other acupoints is beneficial for PONV as well. Additional research needs to be 
done to identify the optimal duration, timing, depths and combinations of acupoints.  
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Table 3 
Best Practice Recommendation Using Supplemental Inspired Oxygen for Prevention and 
Treatment of PONV 
Recommendation Rationale References Level of 
Evidence 
 
 
 
 
 
 
Provision of high 
intraoperative 
inspired oxygen 
(80%) for those 
at high risk of 
developing 
PONV 
 
 
 
 
 
 
 
High inspired 
oxygen of 80% may 
reduce episodes of 
early POV and late 
PON although it 
does not reduce 
PONV. 
 
  
Šimurina, T., Mraović, B., Mikulandra, 
S., Sonicki, Z., Sulen, N., Dukić, B., & 
Gan, T. J. (2010). Effects of high 
intraoperative inspired oxygen on 
postoperative nausea and vomiting in 
gynecologic laparoscopic surgery. 
Journal of Clinical Anesthesia, 22(7), 
492-498. doi: 
10.1016/j.jclinane.2009.10.013 
 
 
 
 
Level II 
 
Hovaguimian, F., Lysakowski, C., Elia, 
N., & Tramèr, M. R. (2013). Effect of 
intraoperative high inspired oxygen 
fraction on surgical site infection, 
postoperative nausea and vomiting, and 
pulmonary function: systematic review 
and meta-analysis of randomized 
controlled trials. Anesthesiology, 
119(2), 303-316. 
 
Level I 
 
While research regarding the use of high-flow inspired oxygen for PONV has been 
conflicting in the past, the research reviewed in this article found that it has at best a weak effect 
on improving PONV. In a RCT, Šimurina et al. (2010) found that high inspired 80% oxygen can 
reduce early POV, overall it had very little effect on PONV. Additionally, Hovaguimian et al. 
(2013) found that 80% oxygen had a beneficial effect on late PON alone and not on PONV. The 
remainder of the articles reviewed in this thesis indicate no positive benefit of using high 
inspired for prevention or treatment of PONV regardless of the type of surgery. 
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Table 4 
Best Practice Recommendation Using Supplemental Intravenous Hydration for Prevention and 
Treatment of PONV 
Recommendation Rationale References Level of 
Evidence 
 
 
 
 
 
 
 
 
 
 
Provision of 
liberal 
intraoperative 
supplemental 
crystalloid 
intravenous 
hydration of 30 
mL/kg/hr 
  
 
 
 
 
 
 
 
 
Liberal intraoperative 
supplemental 
intravenous hydration 
with lactated Ringer’s 
solutions reduces 
incidence of PONV, 
reduces use of rescue 
antiemetics and 
reduces the thirst and 
fluids consumed 
postoperatively. 
  
 
Ashok, V., Bala, I,. Bharti, N., Jain, 
D., & Samujh, R. (2017). Effects of 
intraoperative liberal fluid therapy on 
postoperative nausea and vomiting in 
children – a randomized controlled 
trial. Pediatric Anesthesia, 27, 810-
815. doi: 10.1111/pan.13179 
 
 
 
 
Level II 
 
Elgueta, M. F., Echevarría, G. C., De 
la Fuente, N., Cabrera, F., 
Valderrama, A., Cabezón, R… & 
Cortinez, L. I. (2013). Effect of 
intravenous fluid therapy on 
postoperative vomiting in children 
undergoing tonsillectomy. British 
Journal of Anesthesia, 110(4), 607-
614. doi:10.1093/bja/aes453 
 
 
 
 
 
Level II 
 
Apfel, C. C., Meyer, A., Orhan-
Sungur, M., Jalota, L., Whelan, R. P., 
& Jukar-Rao, S. (2012). Supplemental 
intravenous crystalloids for the 
prevention of postoperative nausea 
and vomiting: quantitative review. 
British Journal of Anesthesia, 108(6), 
893-902. doi: 10.1093/bja/aes138 
 
 
 
 
 
Level I 
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Provision of a 
combination of 
liberal 
intraoperative 
supplemental 
crystalloid 
intravenous 
hydration of 30 
mL/kg/hr in 
conjunction with 
preoperative 0.15 
mg/kg 
dexamethasone 
 
 
Combined liberal 
fluid therapy with 
dexamethasone is 
more effective than 
either monotherapy in 
reducing both the 
incidence and severity 
of PONV, reducing 
the need for rescue 
antiemetics. 
 
Sayed, J. A., Riad, M. A., & Ali, M. 
O. (2016). Comparison of 
dexamethasone or intravenous fluids 
or combination of both on 
postoperative nausea, vomiting and 
pain in pediatric strabismus surgery. 
Journal of Clinical Anesthesia, 34, 
136-142.  doi: 
10.1016/j.jclinane.2016.03.049 
 
 
 
 
Level II 
 
Lambert el al. (2009) site dehydration and hypovolemia as some of the common 
contributing factors of developing PONV and it is no wonder that many of the interventions 
described to correct fluid loss or increase fluids also decreased PONV. Interestingly, Ashok et al. 
(2017) found that those who received liberal amounts of fluid 30 mL/kg/hr compared to the 
standard fluids of 10 mL/kg/hr not only lower levels of PONV but also lower levels of thirst. A 
known risk factor for PONV is “premature oral intake” (Cuthshall & Van Getson, 2014, p. 217), 
and therefore the decreased thirst of patients following intraoperative liberal fluid therapy may 
be of benefit in preventing PONV. An RCT conducted by Lambert et al. (2009) also found there 
to be beneficial effects of a fluid bolus of lactated Ringer’s solution of up to 1,000 mL by 
decreasing episodes of PONV and to have a beneficial effect on systolic blood pressures when 
compared to the traditional methods of fluid therapy. While this is a high quality study with high 
quality evidence, it was conducted almost 10 years ago and the surplus of recent research 
indicating the use of 30 mL/kg/hr of lactated Ringer’s solution seems a more credible 
intervention to suggest. 
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Table 5 
Best Practice Recommendation Pharmacotherapies for Prevention and Treatment of PONV 
Recommendation Rationale References Level of 
Evidence 
 
 
 
 
 
 
Use of 
ondansetron as 
first line 
prophylactic 
pharmacotherapy 
for PONV 
 
 
5HT3 antagonists 
reduce are more 
effective at preventing 
PONV than active 
controls, do not cause 
additional adverse 
effects and reduce the 
need for rescue 
antiemetics. 
Additionally, of the 
5HT3 antagonists 
combined with 
dexamethasone, 
ondansetron and 
dolasetron were found 
to be safest for cardiac 
events with 
ondansetron being 
safest for children. 
 
 
Singhal, A. K., Kannan, S. & Gota, 
V. S. (2012). 5HT3 antagonists for 
prophylaxis of postoperative nausea 
and vomiting in breast surgery: A 
meta-analysis. Journal of 
Postgraduate Medicine, 58(1), 23-
31. 
 
 
 
 
Level I 
 
Tricco, A. C., Soobiah, C., Blondal, 
E., Veroniki, A. A., Khan, P. A., 
Vafaei, A.,…Straus, S. E. (2015). 
Comparative safety of serotonin (5-
HT3) receptor antagonists in patients 
undergoing surgery: a systematic 
review and meta-analysis. BMC 
Medicine, 13(1), 142. doi: 
10.1186/s12916-015-0379-3. 
 
 
 
Level I 
 
 
 
 
 
Combination of 
prophylactic 
dexamethasone 
and ondansetron 
 
 
Ondansetron when 
combined with 
dexamethasone reduces 
PONV more than either 
monotherapy, reduces 
the need for additional 
rescue antiemetics and 
does not produce 
additional adverse 
effects from 
combination therapies.  
 
 
Shen, Y. D., Chen, C. Y., Wu, C. H., 
Cherng, Y. G., & Tam, K. W. 
(2014). Dexamethasone, 
ondansetron, and their combination 
and postoperative nausea and 
vomiting in children undergoing 
strabismus surgery: a meta-analysis 
of randomized controlled trials. 
Pediatric Anesthesia, 24, 490-498. 
doi: 10.1111/pan.12374 
 
 
 
 
Level I 
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Awad, K., Ahmed, H., Abushouk, A. 
I., Nahrawi, S. A., Elsherbeny, M. 
Y., Mustafa, S. M., & Attia, A. 
(2016). Dexamethasone combined 
with other antiemetics versus single 
antiemetics for prevention of 
postoperative nausea and vomiting 
after laparoscopic cholecystectomy: 
an updated systematic review and 
meta-analysis. International Journal 
of Surgery, 36, 152-163. doi: 
10.1016/j.ijsu.2016.10.034 
 
 
 
 
Level I 
  
Where Singhal et al. (2012) found 5HT3 receptor antagonists to be the more effective 
than the active controls of pharmacologic agents commonly used to prevent PONV, they also 
found ondansetron to be safest for both children and adults when combined with dexamethasone. 
Tricco et al. (2015) found that when combined with dexamethasone, the 5HT3 antagonists 
improve in efficacy significantly. Additionally, it was found that granisetron when combined 
with dexamethasone may increase the risk for cardiac arrhythmias (Tricco et al., 2015). Wu et al. 
(2013) found that ondansetron and granisetron were equally effective at preventing PONV and 
that there were no significant differences in incidence of PONV, the need for rescue antiemetics 
or headaches. Because of the safety concerns of granisetron and the overall effectivity of 
ondansetron when compared to the other 5HT3 antagonists and when combined with 
dexamethasone, ondansetron should the recommended pharmacotherapy to prevent PONV with 
a combination of dexamethasone pharmacotherapy. 
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CHAPTER 4 
Implementation to Nursing Practice and Evaluation 
Chapter 4 will be centered around implementing integrative therapies to prevent and treat 
PONV occurring in the first 24 postoperative hours into existing nursing practice. The proposed 
implementation will include a proposed best practice guideline to be used preoperatively, 
intraoperatively and postoperatively by healthcare providers for integrative management of 
PONV. This best practice guideline will be translated into standing orders for all surgical and 
postoperative patients and integrated into facility policies and procedures. While the ultimate 
goal is to better prevent and treat PONV, it is crucial to understand if the best practice guideline 
is beneficial in the clinical setting and how it may be better improved. The desire for continued 
improvement of the best practice guideline suggests the need for a method of implementation 
and evaluation that continually assess the efficacy of the guideline once applied. For these 
reasons, both the implementation and evaluation of this best practice guideline will be based on 
the Plan-Do-Study-Act (PDSA) cycle. The PDSA cycle is a tool commonly used to implement 
and to evaluate continuous improvements by healthcare organizations and facilities regarding 
evidence based research (Institute for Healthcare Improvement, 2017). In order to test the 
efficacy of the proposed best practice guideline in the clinical setting, it is prudent to first 
integrate the guideline into small settings, adjust and improve the guideline before expanding the 
application.  For this reason, the proposed guideline will be carried out in a single hospital and 
evaluated on a biannual basis using the PDSA cycle. Implementation of this best practice 
guideline will be explored through the “plan” and “do” sections of the cycle while evaluation of 
the implementation will be explored through the “study” and “act” sections of the cycle (Institute 
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for Healthcare Improvement, 2017). The final portions of this chapter will include the strengths 
and limitations of this honors thesis as well as a discussion on areas of future research.  
Implementation 
Plan 
 The first part of the PDSA cycle is the planning which includes refining the objective, 
predictions, and all of the specifics surrounding the specific action (Institute for Healthcare 
Improvement, 2017). The plan section of the PDSA cycle is what will guide the implementation 
of the best practice guideline for treating and preventing PONV into the clinical setting. The 
objective for implementing this best practice guideline into the clinical setting is to reduce the 
episodes and severity of PONV for patients within the first 24 hours who underwent surgery 
under general anesthesia. Through implementation of the best practice guideline, it can be 
hypothesized that both episodes and severity of PONV will be reduced in the first 24 hours 
following surgery under general anesthesia. 
 The specific interventions found to be beneficial, as described in Chapter 3, will be 
integrated into a standardized clinical protocol or intervention bundle and standing surgical and 
postoperative orders at a single hospital. The bundle includes pre-operative, intraoperative, and 
post-operative interventions as outlined below. Please see the corresponding table outlining 
implementations regarding timing below. As part of the bundle, prior to surgery, each patient 
will be educated on controlled breathing exercises by their nurse and asked to complete a 
questionnaire regarding their personal risk factors for developing PONV. Additionally, each 
patient will be provided information about acupuncture and the reduction of PONV associated 
with it. Each patient will then be given the option to sign a consent for intraoperative 
acupuncture for the purposes of reducing PONV.  For all patients, an infusion of lactated 
INTEGRATIVE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING: A 
BEST PRACTICE APPROACH  
81 
Ringer’s solution with a rate of 30 mL/kg/hr will be given intraoperatively. All patients will 
receive standard doses of ondansetron in combination with dexamethasone as prophylactic 
treatment for PONV during the peri-operative period according to facility standards. For patients 
with multiple risk factors for developing PONV, 0.15 mg/kg dexamethasone will be given prior 
to induction of anesthesia. All patients will receive acupuncture stimulation of acupoint P6 
intraoperatively. At the first report of nausea or vomiting, the postoperative nurse will guide the 
patient through the controlled breathing exercises taught in the preoperative setting.   
Table 6 
Timing of Interventions of Care Bundle 
Preoperative Interventions Intra-operative Interventions Postoperative Interventions 
 
Controlled breathing 
education 
 
 
IV infusion of lactated 
ringers at 30 mL/kg/hr 
 
Practice of controlled 
breathing with nurse in PACU 
if PONV occurs 
 
 
Personal PONV risk factor 
questionnaire completion 
with pre-operative nurse 
 
 
Standard prophylactic 
ondansetron dose 
 
 
Education on intraoperative 
acupuncture 
 
Prophylactic dexamethasone 
dose of 0.15 mg/kg for high 
risk patients prior to 
anesthesia induction 
 
 
 
Acquire or document refusal 
of informed consent on 
intraoperative acupuncture 
 
Stimulation of acupuncture 
point P6 if informed consent 
signed in pre-operative area 
 
 
 
The best practice guideline provided to nursing staff, surgeons, anesthesiologists and 
acupuncturists will include rationales with supporting documentation for the aforementioned 
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interventions to encourage adoption of these guidelines in the clinical setting. To encourage 
interdisciplinary collaboration, a perioperative meeting will be held where all relevant personnel 
will be taught the entire protocol and how the other healthcare members will be a part of the 
implementation. During this meeting, the interdisciplinary team will have a discussion regarding 
areas of concern before establishing consensus on the proposed guidelines for the new 
implementation. The interventions will be added to standing orders for all surgical patients and 
postoperative patients. Based on the recommendations found in Chapter 3, peri-operative nursing 
staff will be the drivers of force in implementing this best practice guideline. Peri-operative 
nurse managers and charge nurses will be responsible for holding a staff meeting educating about 
the best practice guideline and how it will alter or enhance existing agency specific policies and 
procedures. All peri-operative nurses will be required to attend or complete a standardized course 
on controlled breathing exercises prior to teaching and implementing this technique with 
patients. All peri-operative nurses will be trained on applying pressure to acupoint P6 for correct 
acupressure intervention. A licensed acupuncturist will be hired to complete all intraoperative 
acupuncture. If and when the licensed acupuncturist cannot attend surgery, nursing staff trained 
acupressure of acupoint P6 will complete intraoperative acupressure. All required trainings and 
continuing education courses associated with this clinical protocol will be provided to nursing 
staff on the clock while being paid in order to convey the facility commitment to success of the 
protocol and education of their nursing staff.  
The last portion of the “plan” section is to develop a plan to evaluate the effect of the 
implementation (Institute for Healthcare Improvement, 2017). In order to evaluate the efficacy of 
the clinical protocol bundle, in a follow up phone call, all patients will be asked a series of 
questions related to satisfaction including overall comfort level, responsiveness of nursing staff, 
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and areas that they would like to see changed. On the other end of the spectrum, each nurse will 
be asked to record the episodes of nausea and vomiting encountered by each patient, the time at 
which the episodes took place and the severity of the episodes using a standardized scale. The 
results of both patient satisfaction and nursing documentation will be compiled and analyzed 
biannually for recurring trends and for future analysis. Additionally, quality and safety 
monitoring will include review of patient charts and incident reports every two weeks for the 
first eight weeks. Following the first eight weeks, the data will then be reviewed every two 
months over a four month period and then quarterly until full implementation has been achieved. 
By reviewing quality and safety measures more frequently at the beginning of the 
implementation, the healthcare teams and those implementing this bundle may make adjustments 
and focus on areas of concern as they proceed.  
Do 
 The “do” portion of the PDSA cycle involves carrying out the implementation, collecting 
data and information regarding success or problems encountered (Institute for Healthcare 
Improvement, 2017). In this stage of the cycle, the implementation will be carried out on a small 
scale in one hospital as previously mentioned. The plan to evaluate change as outlined above will 
be carried out and analyzed every two weeks for the first eight weeks, then every two months for 
the following four months, and then quarterly until implementation is complete. By monitoring 
the care bundle more frequently at the beginning of implementation, adjustments can be made to 
enhance the long term success and quality of care delivered. Similarly, peri-operative nursing 
staff will also be asked to complete a survey monthly for the first quarter and then quarterly 
thereafter  through secure email regarding their perception of the success or failure of integrating 
the guideline into clinical protocol. By evaluating the more frequent responses of nurse surveys 
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at the beginning of the process, the bundle and standing orders can be adapted to better 
implement the guideline into clinical protocol. The nursing staff will be asked if they have 
suggestions for improvement as well as what they believe is working well and can be expanded 
upon.  
Evaluation 
Study 
 The “study” portion of the PDSA cycle involves fully analyzing data collected in 
previous stages and applying those results (Institute for Healthcare Improvement, 2017). While 
analyzing the data including both nurse and patient satisfactions with the protocol as well as 
nurse assessment data on frequency and intensity of PONV episodes, the hypothesis that 
frequency and severity of PONV will be decreased will be evaluated as well (Institute for 
Healthcare Improvement, 2017). During the biannual analysis and compiling of data, the current 
results will be compared to previous data sets to analyze for any changes in data, improvements 
or worsening of PONV in the facility. In comparing the hypothesis to what actually happened 
based on the data, the team will begin to understand if their objective was met and if not what 
happened instead.  
Act 
 The “act” portion of the PDSA cycle involves evaluating where changes need to be made 
and which specific changes need to be carried out to better reach the objective of the 
implementation (Institute for Healthcare Improvement, 2017). By pulling conclusions from the 
“study” section and what the end results were, the team will then develop a plan for improving 
and implementing alterations to the original protocols. Possible areas to be considered for 
improvements are duration of acupuncture, doses of dexamethasone and ondansetron and total 
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fluid volumes to be infused intraoperatively. The conclusions made and plan that was developed 
in the “act” stage of the initial PDSA cycle will guide the “plan” section of the following PDSA 
cycle (Institute for Healthcare Improvement, 2017). The PDSA cycle will repeat indefinitely 
until there is a professional consensus as to the success of the protocol and when all objectives of 
the protocol are met to reduce the overall severity and incidence of PONV in the first 24 
postoperative hours for patients undergoing general anesthesia. 
Strengths and Limitations of Honors Thesis 
 This honors thesis possesses many strengths including an extensive review of literature, a 
comprehensive analysis of individual recommendations and a concise yet thorough set of 
recommendations for each modality of management of PONV studied. While PONV is a 
common and distressing effect many face following surgery, there is still much research needed 
to fully eradicate the unpleasant phenomenon. While extensive, this honors thesis only brushed 
the surface of all potential modalities and protocols available to manage PONV and exemplifies 
the fact that extensive research has yet to be done.  The conclusions reached in this thesis are 
largely generalizable to larger populations as the majority of sources included demographics 
from a wide variety of patients under general anesthesia. Additionally, the conclusions reached 
in this honors thesis are clinically applicable and cost effective. All sources included in this 
thesis were under 10 years old and include the most current and relevant research on the topics of 
PONV and management thereof. 
 A final and particularly important strong point of this honors thesis is that it incorporates 
many integrative nursing principles. The fourth integrative nursing principle that “integrative 
nursing is person-centered and relationship-based” emphasizes that each patient has a different 
context of illness that requires nurses develop authentic relationships with patients to tailor their 
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care (Kreitzer, 2015). The bundled protocol proposed in this thesis takes into account the fact 
that each patient responds differently to treatment and therefore multiple options and overlapping 
treatments should be available. Additionally, as each patient may respond differently to different 
medications, reducing the amount of rescue antiemetics used decreases potential side effects, 
reduces the use of potentially unnecessary medications, and reduces the cost of treatment both to 
the patient and the healthcare facility. By treating symptoms before they become extreme and 
cause further complications, healthcare teams can provide more efficient and proactive care. The 
cost of the complications of not adequately preventing PONV is increased as the patient stays 
longer, requires more time and attention, and requires more medications and monitoring. By 
reducing the incidence of symptoms, this bundled protocol to prevent PONV has the potential to 
decrease the overall cost of postoperative patients experiencing PONV. The fifth integrative 
nursing principle that states that “integrative nursing is informed by evidence” is particularly 
emphasized in this honors thesis (Kreitzer, 2015). Through an extensive literature review with up 
to date articles, I gathered the most relevant and influential data to propose the bundled 
intervention outlined above. The second integrative nursing principle states that “human beings 
have the innate capacity for health and wellbeing” is also represented in this thesis (Kreitzer, 
2015). By providing patients with effective modalities of PONV management, the patient is 
therefore exposed to less potential injury, decrease in quality of life, more efficient rest and 
therefore are on a faster path to healing and well-being.  
This honors thesis possesses several limitations as well as strengths. The thesis was 
limited in that it was not a systematic review including all literature on the included topics and 
instead focused on data published within the past 10 years. Many of the articles included in this 
thesis focused on specific patient populations and surgery types which may limit the 
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generalizability of their results. An additional limitation stems from the fact that not all studies 
analyzed in this thesis occurred in Western hospitals and in overseas hospitals with the same 
standards of care. These foreign hospitals may not be representative of the type of clinical setting 
that the best practice guideline defined in this thesis will attempt to enhance. While the results 
are clinically applicable, the integration of acupuncture of acupoint P6 into every operative room 
for intraoperative treatment could prove difficult. Both training and hiring of certified 
acupuncturists staffing could be difficult. Not every patient may feel comfortable receiving 
intraoperative acupuncture and therefore it is possible that not every patient will consent to it.  
Additionally, depending on the type of surgery and positioning of the patient during surgery, it 
may be difficult or impossible to access the acupoint P6 for every patient.  
Perhaps the greatest limitation of this honors thesis is that very few of the presented 
studies researched the modalities for PONV management in an integrative way. For example, 
while each study may have tested a modality while controlling all other variables or types of 
modalities, there were still other modalities used. Where the use of pharmacotherapies was being 
tested, each patient still received intraoperative intravenous fluids. Where the use of 
supplemental oxygen was being tested, pharmacotherapies were still being used. Without the 
isolation of each modality to be studied, it is nearly impossible to know if this modality alone is 
sufficient in managing PONV. Integrative nursing focuses on the whole being of the person and 
takes into account both their mind and body (Ringdahl, 2014). Additionally, an integrative nurse 
incorporates the least to most intensive treatments available to heal or improve the health of their 
patients (Ringdahl, 2014). Until each modality presented in this thesis is explored independent of 
current treatments, it will be impossible to develop an integrative protocol moving from the least 
to most invasive. The literature presented in this thesis provides strong evidence for the 
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recommendation of a general protocol and therefore has a long way to go before it can be truly 
called integrative. 
Summary 
 The purpose of this honors thesis was to develop best practice recommendations to 
reduce the incidence and severity of PONV within the first 24 postoperative hours in patients 
who undergo procedures under general anesthesia. Extensive and diverse research has been 
conducted as to the efficacy of individual and combination modalities however as many as 20-
30% of all patients still experience PONV (Cutshall & Van Getson, 2014). This alarming 
proportion of patients experiencing such an unpleasant phenomenon indicates a lack of accuracy 
in treatment approaches and failure to prevent PONV from occurring. PONV not only is an 
unpleasant experience but increases postoperative complications, increases length of stay, 
increases cost of treatment and increases labor required from nursing staff (Cutshall & Van 
Getson, 2014). Many of the modalities used to manage and prevent PONV are medications 
which may be expensive and introduce a host of side effects and adverse reactions. By 
introducing additional modalities to treat and manage PONV such as intraoperative fluid boluses 
and acupuncture, many patients may not require or be exposed to additional expensive and 
potential harmful pharmacologic agents. Extensive research is needed to determine the efficacies 
of each modality on its own for management of PONV as well how to better identify at risk 
patients and decrease the amount of postoperative opioid use. The PDSA cycle as outlined in 
Chapter 4 provides health care settings a tool to evaluate the introduction and adjustments used 
in relation to the proposed best practice recommendation. Overall, the implementation of the 
proposed best practice guideline into clinical protocols will reduce the incidence and severity of 
PONV in the first 24 postoperative hours for patients undergoing procedures under general 
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anesthesia. The reduction in PONV is one step to fully eradicating PONV and improving 
postoperative care for patients and healthcare providers alike. 
  
INTEGRATIVE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING: A 
BEST PRACTICE APPROACH  
90 
References 
Adib-Hajbaghery, M., Hosseini, F. S. (2015). Investigating the effects of inhaling ginger essence 
of post-nephrectomy nausea and vomiting. Complementary Therapies in Medicine, 23(6), 
827-831. doi: 10.1016/j.ctim.2015.10.002 
Albooghobeish, M., Mohtadi, A., Saidkhani, V., Fallah, H., Behaein, K., Nesionpour, S., & 
Nikbakht, R. (2017). Comparison between effects of acupuncture and metoclopramide on 
postoperative nausea and vomiting after gynaecological laparoscopy: a randomized 
controlled trial. Anesthesiology and Pain Medicine, 7(5). doi: 10.5812/aapm.12876 
Apfel, C. C., Meyer, A., Orhan-Sungur, M., Jalota, L., Whelan, R. P., & Jukar-Rao, S. (2012). 
Supplemental intravenous crystalloids for the prevention of postoperative nausea and 
vomiting: quantitative review. British Journal of Anesthesia, 108(6), 893-902. doi: 
10.1093/bja/aes138 
Ashok, V., Bala, I,. Bharti, N., Jain, D., & Samujh, R. (2017). Effects of intraoperative liberal 
fluid therapy on postoperative nausea and vomiting in children – a randomized controlled 
trial. Pediatric Anesthesia, 27, 810-815. doi: 10.1111/pan.13179  
Awad, K., Ahmed, H., Abushouk, A. I., Nahrawi, S. A., Elsherbeny, M. Y., Mustafa, S. M., & 
Attia, A. (2016). Dexamethasone combined with other antiemetics versus single 
antiemetics for prevention of postoperative nausea and vomiting after laparoscopic 
cholecystectomy: an updated systematic review and meta-analysis. International Journal 
of Surgery, 36, 152-163. doi: 10.1016/j.ijsu.2016.10.034 
Bakhshaei, M. H., Khoshraftar, E., Shoja, S., & Mehrabi S. (2018). Comparison of wrist 
acupuncture point P6 with pharmacologic management to prevent postoperative nausea 
INTEGRATIVE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING: A 
BEST PRACTICE APPROACH  
91 
and vomiting in patient’s undergoing laparotomy: a double blind study. World Family 
Medicine, 16(2), 73-76. doi: 10.5742/MEWFM.2018.93242 
Briggs, P., Hawrylack, H., & Mooney, R. (2016). Inhaled peppermint oil for postop nausea in 
patients undergoing cardiac surgery. Nursing2016, 46(7), 61-67. doi: 
10.1097/01.NURSE.0000482882.38607.5c 
Cheong, K. B., Zhang, J., Huang, Y., & Zhang, Z. (2013). The effectiveness of acupuncture in 
prevention and treatment of postoperative nausea and vomiting – a systematic review and 
meta-analysis. PLoS One, 8(12). doi: 10.137/journal.pone.0082474 
Cronin, S. N., Odom-Forren, J., Roberts, H., Thomas, M., Williams, S., & Wright, M. I. (2015). 
Effects of controlled breathing, with or without aromatherapy, in the treatment of 
postoperative nausea. Journal of PeriAnesthesia Nursing, 30(5), 389-397. doi: 
10.1016/j.jopan.2015.03.010 
Cutshall, M. C. & Van Getson, L. M. (Eds.). (2014). Integrative nursing management of nausea. 
In M. J. Kreitzer & M. Koithan, Integrative nursing (pp. 214-229). New York, NY: 
Oxford University Press. 
Elgueta, M. F., Echevarría, G. C., De la Fuente, N., Cabrera, F., Valderrama, A., Cabezón, R… 
& Cortinez, L. I. (2013). Effect of intravenous fluid therapy on postoperative vomiting in 
children undergoing tonsillectomy. British Journal of Anesthesia, 110(4), 607-614. 
doi:10.1093/bja/aes453  
Guayatt, G. and Rennie, D. (2002) as cited in Melnyk, B. M. & Fineout-Overholt, E. (2011). 
Evidence-based practice in nursing and healthcare: A guide to best practice. 
INTEGRATIVE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING: A 
BEST PRACTICE APPROACH  
92 
Hines, S., Steels, E., Chang, A., & Gibbons, K. (2018) Aromatherapy for treatment of 
postoperative nausea and vomiting (review). Cochrane Database of Systematic Reviews, 
3. doi: 10.1002/14651858.CD007598.pub3 
Horn, C. C., Wallisch, W. J., Homanics, G. E., & Williams, J. P. (2014). Pathophysiological and 
neurochemical mechanisms of postoperative nausea and vomiting. European Journal of 
Pharmacology, 5(722), 55-66. doi: 10.1016/j.ejphar.2013.10.037 
Hovaguimian, F., Lysakowski, C., Elia, N., & Tramèr, M. R. (2013). Effect of intraoperative 
high inspired oxygen fraction on surgical site infection, postoperative nausea and 
vomiting, and pulmonary function: systematic review and meta-analysis of randomized 
controlled trials. Anesthesiology, 119(2), 303-316. 
Institute for Healthcare Improvement. (2017). Science of improvement: Testing changes. 
Retrieved from 
http://www.ihi.org/resources/Pages/HowtoImprove/ScienceofImprovementTestingChang
es.aspx 
Izadi, P., Delavar, P., Yarmohammadi, M. E., Daneshmandan, N., & Sadrameli, M. (2016). 
Effect of supplemental oxygen 80 % on post-tonsillectomy nausea and vomiting: a 
randomized controlled trial. European Archives of Oto-Rhino-Laryngology, 273(5), 
1215-1219. doi: 10.1007/s00405-015-3858-4 
Kreitzer, M. J.  (2015). Integrative nursing: Application of principles across clinical settings. 
Rambam Maimonides Medical Journal, 6(2).  doi: 10.5041/RMMJ.10200 
Lambert, K. G., Wakim, J. H., & Lambert, N. E. (2009). Preoperative fluid bolus and reduction 
of postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic 
surgery. AANA Journal, 77(2), 110-114. 
INTEGRATIVE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING: A 
BEST PRACTICE APPROACH  
93 
Lee, A., Chan, S., & Fan, L. (2015). Stimulation of the wrist acupuncture point PC6 for 
preventing postoperative nausea and vomiting (review). Cochrane Database of 
Systematic Reviews, 11. doi: 10.1002/14651858.CD003281.pub4 
Lee, Y. R., & Shin, H. S. (2017). Effectiveness of ginger essential oil on postoperative nausea 
and vomiting in abdominal surgery patients. The Journal of Alternative and 
Complementary Medicine, 23(3), 196-200. doi: 10.1089/acm.2015.0328 
McKeen, D. M., Arellano, R., & O’Connell, C. (2009). Supplemental oxygen does not prevent 
postoperative nausea and vomiting after gynecological laparoscopy. Canadian Journal of 
Anesthesiology, 56(9), 651-657. doi: 10.1007/s12630-009-9136-4 
Orhan-Sungur, M., Kranke, P., Sessler, D., & Apfel, C. C. (2008). Does supplemental oxygen 
reduce postoperative nausea and vomiting? A meta-analysis of randomized controlled 
trials. Anesthesia & Analgesia, 106(6), 1733-1738. doi: 10.1213/ane.0b013e3181731c5a 
Parra-Sanchez, I., Abdallah, R., You, J., Fu. A. Z., Grady, M., Cummings III, K., … Sessler, D. 
I. (2013). A time-motional economic analysis of postoperative nausea and vomiting in 
ambulatory surgery. Canadian Journal of Anesthesiology, 59(4), 366-375. doi: 
10.1007/s12630-011-9660-x 
Pellegrini, J., DeLoge, J,. Bennet, J., & Kelly, J. (2009). Comparison of inhalation of isopropyl 
alcohol vs promethazine in treatment of postoperative nausea and vomiting (PONV) in 
patients identified as at high risk for developing PONV. AANA Journal, 77(4), 293-299. 
Ringdahl, D. (2014). Integrative nursing and symptom management. In M. J. Kreitzer & M. 
Koithan (Eds), Integrative nursing (pp. 187-199). New York, NY: Oxford University 
Press. 
INTEGRATIVE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING: A 
BEST PRACTICE APPROACH  
94 
Sayed, J. A., Riad, M. A., & Ali, M. O. (2016). Comparison of dexamethasone or intravenous 
fluids or combination of both on postoperative nausea, vomiting and pain in pediatric 
strabismus surgery. Journal of Clinical Anesthesia, 34, 136-142.  doi: 
10.1016/j.jclinane.2016.03.049 
Shen, Y. D., Chen, C. Y., Wu, C. H., Cherng, Y. G., & Tam, K. W. (2014). Dexamethasone, 
ondansetron, and their combination and postoperative nausea and vomiting in children 
undergoing strabismus surgery: a meta-analysis of randomized controlled trials. Pediatric 
Anesthesia, 24, 490-498. doi: 10.1111/pan.12374 
Shin, H. C., Kim, J. S., Lee, S. K., Kwon, S. H., Kim, M. S., Lee, E. J., & Yoon, Y. J. (2016). 
The effect of acupuncture on postoperative nausea and vomiting after pediatric 
tonsillectomy: A meta-analysis and systematic review. The Laryngoscope, 126(8), 1761-
1767. doi: http://dx.doi.org.ezproxy4.library.arizona.edu/10.1002/lary.25883 
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